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Satellite cells are known as the definitive muscle stem cells and are responsible for 
skeletal muscle maintenance and repair. The capacity of these satellite cells to 
participate in myogenesis decreases with age and as a result, muscle repair and 
maintenance in an aging organism is characterized by fibrosis, lipid accumulation and 
atrophy, a process known as sarcopenia. Recent parabiotic studies have shown that 
satellite cells with reduced myogenic capability in aging muscle can be rejuvenated to 
undergo effective myogenesis when exposed to a young environment. Further analysis 
has suggested that the Wnt family of signaling proteins identified in serum is pivotal in 
regulating cell fate, proliferation and differentiation, during aging. Wnt3a is known to 
regulate fibrogenensis, Wnt10b adipogenesis and Wnt7 myogenesis. In the current 
study, we aim to determine the cytosolic and secreted expression profiles of the three 
Wnt isoforms, Wnt3a, 7 and 10b, during myogenesis of early and late passage C2C12 
myoblasts. We then extend our analysis to determine whether conditioned media 
could improve the myogenic capacity of late passage cells. 
 
Late passage C2C12 cells had elevated Wnt3a cytosolic levels along with reduced 
differentiation capacity and a rapidly declining Wnt7 levels, in comparison to early 
passage cells. The elevated Wnt3a suggests an elevated fibrogenic predisposition, 
whereas the declining Wnt7 cytosolic levels, a decrease in myogenic capacity. 
Furthermore, analysis of the secreted vs. cytosolic ratio in Wnt7 levels revealed a more 
rapid decline in late vs. early passage cells during differentiation, supporting the 
observed decreased myogenic ability. Moreover, late passage cells also showed lower 
Wnt10b levels compared to early passage cells. This low level of Wnt10b is likely 
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associated with an increase in adipogenic predisposition. The results obtained in the 
cross-over experiments indicated that conditioned media from early passage cells did 
not improve the differentiation of late passage cells by the low levels of Myogenin and 
MHC. However, early passage cells treated with conditioned media from late passage 
cells surprisingly showed a marginal increase in both Myogenin and MHC levels. 
Interestingly, cytosolic Wnt3a and 7 in late passage cells treated with ‘young media’ 
were increased compared to control whereas early passage cells treated with ‘old’ 
media showed significantly decreased levels of Wnt3a and 7. Furthermore, early 
passage cells acquired a declining expression when treated with ‘young’ media 
whereas late passage cells had an increasing level when treated with ‘old’ media. This 
indicates a possible improvement in differentiation in late passage cells.  
 
Taken together, our results support a role for Wnt7 and Wnt10b in promoting 
myogenesis while Wnt3a may decrease myogenesis. With the increase in passage 
numbers, the reduced myogenic predisposition is regulated by reduced Wnt10b, 7 and 
elevated Wnt3a levels, respectively. Moreover, we speculate that the lack of myogenic 
improvement in the cross-over experiment could be the presence of unknown secreted 
factors in ‘young’ media that impedes myogenesis. Finally, cell lines are known to be 
biologically different to primary myoblasts through the accumulation of mutations 
which could render the cells less sensitive to growth factors. Therefore, it is imperative 
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Maintenance and repair of skeletal muscle is mediated primarily by resident muscle 
stem cells known as satellite cells and to a lesser extent by other muscle-derived and 
non-muscle-derived stem cells. Satellite cells, which reside in their niche in a quiescent 
state, are activated in response to injury or trauma and begin to proliferate (now called 
myoblasts). Several myoblasts return to quiescence to replenish the satellite cell 
population, whereas the rest eventually fuse into myotubes thus facilitating 
maintenance and repair (Kuang and Rudnicki, 2008). This process is highly efficient in a 
young individual, however, the capacity for maintenance and repair declines with an 
increase in age, a process known as sarcopenia (Solomon and Bouloux, 2006). 
Sarcopenic muscles are aging muscles characterized by reduced muscle mass (atrophy) 
with the accumulation of lipids and fibrosis (Brack et al., 2007; Vertino et al., 2005). 
This age-related decline in regenerative capacity by satellite cells has generated much 
debate about the possible cause; specifically the role of extrinsic vs. intrinsic factors 
remains elusive. The characteristic changes in sarcopenic muscle leads to an altered 
extrinsic environment which together, directly impact satellite cell function. The altered  
intrinsic properties of satellite cells from aging muscle include impaired myogenic 
regulatory factor activities (Degens, 2007). Lastly, quiescent satellite cell numbers have 
been shown to be reduced in aging muscle (Shefer et al., 2006). This reduction in 
numbers could be one of the many causes of reduced satellite cell function.  
 
Recent evidence, through parabiotic pairing experiments, suggest that serum factors 
from the circulatory system of young mice can rejuvenate the regenerative capacity of 
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satellite cells in old mice (Brack and Rando, 2007; Conboy et al., 2005). Further studies 
identified high levels of Wnt proteins in the serum of old mice, leading to elevated 
signaling via β-catenin dependent pathway (Brack et al., 2007). Inhibition of the Wnt 
signaling pathway through the extensive use of antagonists resulted in successful 
myogenic regeneration (Brack et al., 2007). Additionally, antagonizing this pathway 
reduced the tendency of satellite cells to undergo cell fate alteration from a myogenic 
to a fibrogenic lineage (Brack et al., 2007). Therefore, this study has implicated the 
possible role of Wnt signaling in regulating satellite cell function in aging muscle. 
 
Wnt proteins act via either the canonical or non-canonical pathways that regulate 
cellular processes such as migration, apoptosis, differentiation and myogenic 
specification (Brack et al., 2008; Polesskaya et al., 2003). Although it is well accepted 
that Wnt proteins control differentiation and myogenic progression, the exact role of 
the canonical vs. non-canonical pathways is unclear. Myogenic differentiation requires 
a highly regulated molecular switch of Notch to Wnt signaling, initiated by Wnt3a 
(Brack et al., 2008). However, an elevated Wnt3a level in aging muscle (which shows an 
increase in fibrogenic fate) suggests a role for this isoform in fibrogenesis rather than 
myogenesis (Brack et al., 2007). On the other hand, muscle-derived CD45+ cells from 
uninjured muscles are capable of myogenic potential in the presence of Wnt5a, 5b, 7a 
and 7b proteins (Polesskaya et al., 2003). Isolated myoblasts from aging mice, which 
display a lineage change from myogenic to adipogenic lineage, have been shown to 
have low Wnt10b levels (Taylor-Jones et al., 2002). Similar results were observed in 
myoblasts of Wnt10b-/- mice where the lack of Wnt10b and absence of Wnt7b 
compensation, leads to lineage change from myogenic to adipogenic lineage and 
ultimately lipid accumulation (Vertino et al., 2005). This chapter presents an overview 
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of the Wnt signal transduction and its role in regulating satellite cell myogenesis in the 
skeletal muscle aging process. 
 
1.2 Satellite cell characterization 
First identified by Mauro (1961) in leg muscles of frogs, satellite cells were primarily 
identified in situ by their morphological characteristics and anatomical location. 
Subsequent analysis by Muir et al. (1965) revealed the presence of satellite cells in 
muscles of white mice and fruit bats, in addition, a detailed distribution and cellular 
structure. Identification by electron microscopy (EM) highlighted their unique niche, 
located between the basal lamina and sarcolemma, and positioned along the entire 
length of myofibers (Muir et al., 1965) (Fig. 1.1). Important morphological 
characteristics include fusiform shape, reduced organelle content, smaller nucleus with 
increase amount of heterochromatin compared to the surrounding myonuclei and an 
increase in nuclear-to-cytoplasmic ratio (Charge and Rudnicki, 2004; Mauro, 1961). 
These characteristics indicate that satellite cells are mitotically quiescent (Charge and 
Rudnicki, 2004). 
 
Since its discovery, satellite cells were speculated to play a role in muscle repair and 
regeneration. Indeed, Snow (1978) through trace studies using autoradiography 
demonstrated that satellite cells contribute to regeneration in muscles of young 
Sprague-Dawley rats. Furthermore, in vitro studies have shown that, when satellite 
cells are extracted from the niche and maintained in culture, the activated satellite cells 























Fig. 1.1: Satellite cell morphology and its unique anatomical niche  
Satellite cells (SC) are characterized by their unique niche. Longitudinal view of satellite cells reveals that 
anatomically, satellite cells are located between the sarcolemma (S) and the basal lamina (BL) along the 
entire length of myofibers (A and D). Distinction of satellite cells from myonuclei (arrow heads) is difficult 
under light microscopy as both are situated on the periphery of myofibers (B). The advancement of 
microscopy and the discovery of molecular markers such as Pax7 allowed the identification of the 
satellite cells under fluorescence microscopy (C). Images adopted from (A) Mauro (1961), (B) Muir et al. 
(1965), and (C) Zammit et al (2004). 
 
Subsequently, the transplantation of cultured satellite cells into irradiated mice has 
demonstrated that the transplanted satellite cells can replenish the depleted satellite 
cell pool and contributed to new myofiber formation (Blaveri et al., 1999). Moreover, 
knock-out studies in mice lacking Pax7 (Pax7-/- mice) revealed the lack of muscle 
satellite cells and hence resulted in compromised muscle regeneration (Buckingham, 
2007; Seale et al., 2000). These findings underscore the myogenic potential of satellite 

















their revised characterization that not only includes anatomical location but molecular 
marker expression (section 1.3) and myogenic function. Due to these properties, 
satellite cells are known as the definitive stem cells of skeletal muscle (Brack and Rando, 
2007). 
 
1.3 Molecular regulation of satellite cell myogenesis  
While the identification of satellite cells is achievable with electron microscopy due to 
their characteristic ultra-structure, it is impossible to distinguish satellite cells from 
myonuclei under light microscopy. The advancement in microscopy and discovery of 
molecular markers allowed further characterization and identification of quiescent 
satellite cells (Fig. 1.1). Furthermore, knock-out studies of myogenic genes have 
defined the roles of various myogenic markers such as Pax7 and myogenic regulatory 
factors (MRF). The molecular markers and their respective functions are summarized in 
Table 1.1. 
 
1.3.1 Quiescent satellite cell markers and function 
M-cadherin, the first molecular marker identified by Irintchev et al. (1994), allowed the 
first identification of satellite cells under light microscopy. Through the development of 
in vitro intact single fiber (Bischoff, 1989), studies by Seale et al. (2000) identified Pax7 
(a paired box transcription factor) as a satellite cell marker. Pax7 plays a pivotal role in 
myogenic specification, cell fate alteration, anti-apoptosis and prevention of precocious 
differentiation (Buckingham, 2007; Kuang et al., 2006; Relaix et al., 2006; Seale et al., 
2000; Zammit et al., 2006). Like many molecular markers, the role of Pax7 in 
myogenesis was unraveled in knock-out and transfection studies. Pax7 knock-out 




Table 1.1: Satellite cell markers in myogenesis 
Markers  Expression Function References 
Cell surface  
c-met A Receptor for HGF/SF (Activation) (Cornelison and Wold, 1997) 
VCAM1/VLA4 Q/A Activation  (Seale et al., 2004a) 
NCAM  Q/A/D Fusion of myoblasts (Irintchev et al., 1994) 
M-cadherin Q/A/D Alignment and fusion (Moore and Walsh, 1993) 
CD 34 Q (t)/A (f) Unknown  (Beauchamp et al., 2000) 
SM/C-2.6 Q Unknown  (Fukada et al., 2004) 
Snydecan 3/4 Q ECM signaling  (Cornelison et al., 2001) 
Sphingomyelin Q Cell cycle entry (Nagata et al., 2006) 
Transcription factors 
Pax 7 Q, A, D  Myogenic specification, survival (Seale et al., 2000) 
Pax 3 Q Myogenic specification (Horst et al., 2006) 
PCNA A,P Activation, proliferation (Johnson and Allen, 1993) 
MyoD A Activation, differentiation  (Cornelison et al., 2000) 
Myf 5 Q, A, D Differentiation (Ustanina et al., 2007) 
Myogenin D Differentiation, fusion (Fuchtbauer and Westphal, 1992) 
Mrf 4 D Differentiation, fusion (Jin et al., 2007) 
Others 
Desmin A Cytoskeleton maintanence (Day et al., 2007) 
MHC A, D Differentiation (Bader et al., 1982) 
Abbreviations: Q, quiescence; A, activation; P, proliferation; D, differentiation; VCAM-1/VLA-4, Vascular 
cell adhesion molecule-1/very late antigen-4; NCAM, Neural cell adhesion molecule; t, truncated; f, full; 
Pax, paired-box; PCNA, proliferating cell nuclear antigen; Myf5, myogenic factor 5; Mrf4, myogenic 
regulatory factor 4; MHC, myosin heavy chain 
 
Furthermore, Pax7-/- muscle revealed the complete absence of satellite cells which lead 
to poor myogenesis after cardiotoxin (CTX) injury (Seale et al., 2000). Transfection of 
non-myogenic, muscle derived CD45+:Sca-1+ cells isolated from uninjured muscles with 
Pax7-expressing-retrovirus induced the myogenic program (Seale et al., 2004b). Both 
studies defined the significant role of Pax7 in myogenesis. Another marker discovered 
for the identification of quiescent satellite cells is c-met (Cornelison and Wold, 1997). 
7 
 
The tyrosine receptor kinase, c-met, was detected at the mRNA level by single-cell 
multi-plex RT-PCR in quiescent satellite cells (Cornelison and Wold, 1997). The role of 
c-met is highlighted by the presence of hepatocyte growth factor/scatter factor 
(HGF/SF) in crushed muscles whereby HGF/SF ligand binds to the c-met receptor 
resulting in satellite cell activation (Tatsumi et al., 1998). Further markers include 
VCAM-1 (Seale et al., 2004a) and sphingomyelin (Nagata et al., 2006). The 
calcium-dependent cell adhesion molecule, M-cadherin is also detected at the mRNA 
level, in a subset of quiescent satellite cells, which suggest heterogeneity in the 
satellite cell population (Cornelison and Wold, 1997). Interestingly, cells that express 
M-cadherin also express CD34, a hematopoietic stem cell marker (Beauchamp et al., 
2000). Therefore, CD34 has the potential to be a useful marker for quiescent detection. 
Other discovered markers include syndecan 3 and 4 (Cornelison et al., 2001), and Myf5 
(Beauchamp et al., 2000; Holterman and Rudnicki, 2005). 
 
Although these mentioned markers are useful to identify quiescent satellite cells, none 
of the above mentioned markers are specific to the quiescent population. Furthermore, 
isolation of primary culture satellite cells requires the removal of the cells from their 
niche which inevitably leads to activation. To overcome the activation dilemma, several 
methods have been developed – the ‘G0-myoblast’ and myofiber isolation. Utilizing an 
inhibitor, SB203580, that specifically inhibits the phosphorylation of p38α/β (a mitogen 
activated protein kinase, MAPK), the proliferating cultured myoblast exits the cell cycle 
into a reversible G0-state (Jones et al., 2005). These so called ‘G0-myoblasts’, display 
molecular characteristics similar to quiescent satellite cells. For the myofiber isolation, 
individual myofibers are isolated with adherent satellite cells in a pure state and most 
importantly, activation is delayed (Bischoff, 1989).  
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1.3.2 Myogenic regulatory factors in myogenesis 
In the quiescent state, satellite cells do not display significant expression of MRF at the 
protein and mRNA level (Dhawan and Rando, 2005; Holterman and Rudnicki, 2005). In 
the presence of an injury to skeletal muscle, satellite cells are activated from their 
quiescent state, enter the cell cycle and begin to proliferate. After several cycles, the 
resulting myogenic progenitors (also called myoblasts) fuse and exit the cell cycle to 
enter a state of G0 differentiation and complete the repair of injured skeletal muscle 
(Dhawan and Rando, 2005) (Fig. 1.2). In addition, the myogenic process is accompanied 
by self-renewal, ensuring a constant population after repeated rounds of repair and 
regeneration (Zammit et al., 2004). This comprehensive process of myogenesis is 
mainly regulated by the group of basic helix-loop-helix (bHLH) collectively called the 
MRF that includes MyoD, Myogenin, Myf5 and Mrf4 (Charge and Rudnicki, 2004). 
Activation of satellite cells leads to the down-regulation of Pax7 and the immediate 
sequential up-regulation of MRF, firstly MyoD and Myf5, followed by Myogenin and 
Mrf4 (Cornelison and Wold, 1997; Fuchtbauer and Westphal, 1992). The expression of 
any four MRFs leads to an activation of the myogenic program in the C3H10T1/2 
fibroblast cell line. This remarkable property of MRF was further demonstrated in 
differentiated retinal epithelial cells which will activate the myogenic program in the 
presence of MRFs (Choi et al., 1990). These findings confirm that MRF are indeed the 





















Fig. 1.2: Schematic representation of myogenic lineage progression during skeletal muscle repair and regeneration 
Myogenic lineage progression during muscle repair and regeneration is divided into different stages regulated by molecular markers. Satellite cells (SC) reside 
between the basal lamina and sarcolemma of myofibers in a quiescent state (1). The presence of an injury or trauma in skeletal muscle, activation of satellite cells 
occurs (2), SC enter the cycle giving rise to proliferating myoblasts. After several cycles of division, myoblasts exit the cell cycle (now called myocytes), align and 
undergo differentiation and fusion with existing myofibers or form new multinucleated myotubes (4). Repair and regeneration of skeletal muscle are always 
accompanied by self-renewal (5), therefore, after repeated bouts of repair and regeneration, the quiescent satellite cell population is kept constant. Markers in 
myogenesis are (1) Pax7, quiescence; (2) MyoD, activation; (3) PCNA, proliferation; (4) Myogenin, Mrf4, MHC, differentiation. MyoD, Myf5, Myogenin and Mrf4 
















(4) Differentiation and fusion (3) Proliferation (2) Activation (1) Quiescence 
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1.3.2.1 MyoD and Myf5 
Double knock-outs of MyoD and Myf5 indicated a complete absence of skeletal muscle 
at birth. However, individual knock-outs of MyoD and Myf5 yielded different results 
and gained insight to the role of individual markers. Cultured MyoD knock-out (MyoD-/-) 
myoblasts showed a stellate morphology with severely reduced differentiation with 
continued proliferation even in low-mitogen media (Sabourin et al., 1999). Northern 
blot analysis of Myogenin and Mrf4 showed a delay in both Myogenin and Mrf4 
expression which impeded the MyoD-/- myoblasts from entering the differentiation 
program (Sabourin et al., 1999). However, differentiation deficit and morphology was 
restored when MyoD-/- myoblasts were transfected with a MyoD expressing vector 
(Sabourin et al., 1999). Single fiber cultures with the adherent MyoD-/- quiescent 
satellite cells by Cornelison et al. (2000) confirmed that the differentiation deficit was 
indeed associated with the subsequent delay of Myogenin and Mrf4 expression, and 
additionally M-cadherin which is known to play a role in fusion. The noticeable 
differentiation and repair defect can be seen by the MyoD-/- satellite cell aggregate and 
the ‘forked’ morphology (Cornelison et al., 2000). Genetic profiling performed by Seale 
et al. (2004a) showed that MyoD-/- myoblasts expressed similar markers to quiescent 
satellite cells. In all studies, a notable rise in Myf5 was seen which was speculated to be 
a myogenic compensation effect, however compensation was unsuccessful. Overall, 
these data have identified that the up-regulation of MyoD is essential to initiate the 
myogenic program by initiating Myogenin and Mrf4 expressions. Previously, identifying 
the role of Myf5 in myogenesis has proven to be difficult due to the lack of viable Myf5 
knock-out. Recently, viable Myf5 knock-out (Myf5-/-) mice were generated by Ustanina 
et al. (2007). Likewise to MyoD-/- mice, Myf5-/- mice had a normal muscle development. 
However, unlike MyoD-/- myoblasts, examination of the ultra-structure with electron 
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microscopy indicated no difference in satellite cell morphology and no reduction in 
satellite cell numbers. Interestingly, BrdU incorporation studies on isolated Myf5-/- 
myoblasts showed a delay in proliferation. Furthermore, CTX induced injury to Myf5-/- 
mice showed a delay in muscle repair with fibrotic tissue accumulation but eventually 
repair was completed with no fibrosis (Gayraud-Morel et al., 2007; Ustanina et al., 
2007). Analysis of myogenic regulatory genes indicated that Myogenin, Mrf4 and MHC 
expressions were delayed in Myf5-/- Myoblasts (Gayraud-Morel et al., 2007). In 
summary, data derived from MyoD and Myf5 knock-out studies seem to suggest that 
both transcription factors activate different myogenic programs and that MyoD 
knock-out has a more detrimental effect on myogenesis than Myf5 knock-out. 
Nevertheless, activation of both transcription factors is essential for effective and rapid 
myogenesis.  
 
1.3.2.2 Myogenin and Mrf4 
Following MyoD and Myf5 expression, Myogenin and Mrf4 are expressed leading to 
cell cycle exit in differentiating cells (Charge and Rudnicki, 2004). Similar to the 
difficulty in generating viable Myf5 knock-out mice, Myogenin knock-out mice die at 
birth. However, Knapp et al. (2006) successfully generated viable Myogenin conditional 
mutants by mating mice with floxed alleles of Myogenin to a transgenic mice 
expressing Cre recombinase that deletes Myogenin prior- or post-embryonic muscle 
development, termed Myogflox△/flox△;Cre-ER+ mice. Results from these mutant mice 
indicated that deletion of Myogenin prior to muscle embryonic development lead to 
identical muscle deficiencies to Myogenin knock-outs, ultimately leading to death at 
birth. Post-natal deletions of Myogenin displayed smaller body size in mutant mice but 
surprisingly, a normal myogenesis and muscle growth (Knapp et al., 2006; Meadows et 
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al., 2008). Analysis of MyoD, Myf5 and Mrf4 transcript levels in Myogflox△/flox△;Cre-ER+ 
mice showed insignificant reduced levels compared to wild-type. Furthermore, 
cultured Myogflox△/flox△;Cre-ER+ myoblasts readily form multinucleated myotubes 
indicating that low levels of Myogenin do not affect differentiation (Meadows et al., 
2008). These results seem to suggest that Myogenin is dispensable during post-natal 
myogenesis. Mrf4 knock-out (Mrf4-/-) mice are viable, however developed abnormal 
intercostal muscles, in addition, secondary defects such as abnormal thoracic skeletal 
development (Vivian et al., 2000). Further studies indicated a possible compensation 
effect with the up-regulation MyoD, Myf5 and Myogenin in the Mrf4-/- mice to promote 
myogenesis, however expression and cellular localization study in wild-type mice 
indicated the presence and expression of Mrf4 in differentiated muscle fibers and not 
in satellite cells (Zhou and Bornemann, 2001). Thus, the presence of Mrf4 in myofibers 
indicated a role in myotube maturation; however its absence in satellite cells seems to 
suggest that Mrf4 has a distinct myogenic role to MyoD, Myf5 and Myogenin.  
 
In summary, knock-out mice have defined the individual roles of MRF family of proteins. 
Myf5, Myogenin or Mrf4 knock-outs do not significantly affect proliferation and 
differentiation, however MyoD knock-out lead to a detrimental effect on differentiation 
with continuous proliferation. This shows that MyoD plays a more significant role in 
regulating myogenesis compared to Myf5, Myogenin and Mrf4. Finally, double or triple 
knock-out of any MRF leads to a more noticeable differentiation impairment than 
MyoD knock-out (Gayraud-Morel et al., 2007). Thus, the sequential and collective 





1.4 Myogenic cell lines 
Although myofiber and primary cultures have aided in the discovery of satellite cell 
markers and increased our understanding of myogenesis, both in vitro techniques are 
hampered by several technical difficulties. These include the difficulty in isolating pure 
cultures, their maintenance as well as their limited lifespan in culture. Due to these 
technical difficulties, ‘immortalized’ myogenic cell lines such as mouse C2C12, rat L6 
and mouse MM14 myoblasts are frequently used (Table 1.2). The C2 cell line was 
isolated from thigh muscles of 2 month old C3H mice, 70 hour post crush injury by 
Yaffe and Saxel (1977) and from this cell line, Blau et al. (1985) generated a sub-clone 
called C2C12 cell line by selecting C2 cells that displayed high differentiation capacity. 
The rat L6 cell line was isolated from thigh muscles of new-born rats (Yaffe, 1968) and 
MM14 cell line was derived from leg muscle of 2 month old Balb/C male mice (Linkhart 
et al., 1980). These ‘immortal’ cell lines such as L6 and C2C12 myoblasts can be serially 
maintained over several passages and stored in a frozen state (at -80°C) for extended 
periods (Yaffe, 1968). These advantages make cell lines a popular alternative to primary 
satellite cell cultures. It should be noted that these ‘immortal’ cell lines have an altered 
cell cycle through the accumulation of mutations that allows prolonged maintenance in 
culture (Cornelison, 2008). The mutations that make cell lines different to primary 
myoblasts are unclear. For this reason, studies done on cell lines should be repeated on 
primary cultures for validation purposes. Nevertheless, studies utilizing cell lines have 







Table 1.2: Common myoblast cell lines used to study myogenesis 
Studies utilizing ‘satellite cell-like’ myoblasts are often used to study myogenesis due to their ease of use. 
These myoblast cell lines were generated from primary cultures usually 60 - 70 days post injury and 
serially selected using the pre-plating technique.  
 
1.5 Myogenic cells from other sources 
Tissue-specific stem cells, either muscle-derived or non-muscle-derived, are capable of 
regeneration of the host tissues in which they reside. However, recent evidence 
suggests that stem cells from one tissue can differentiate into cell types other than 
those in the host tissue. For example, hematopoietic stem cells (HSC) found in the bone 
marrow can differentiate into cells of various lineages such as muscle and neurons 
(Asakura, 2003; Asakura and Rudnicki, 2002). Similarly, satellite cells under different 
conditions are capable of differentiating into adipoctyes, osteocytes and fibroblasts 
(Asakura et al., 2001; Brack et al., 2007). Moreover, stem cells isolated from skeletal 
muscle were shown to have hematopoietic potential and readily differentiate into 
hematopoietic colonies in vitro (Jackson et al., 1999). Taken together, these results 
suggest that tissue-specific stem cells can differentiate into many cell types depending 
on the extrinsic signals provided by the host tissue. The identified myogenic stem cells 
from various sources are listed in Table 1.3, and some will be discussed below. 
 
1.5.1 Muscle derived myogenic cells 
Muscle-derived hematopoietic stem cells (CD45, CD34 and Sca-1 positive), display 
Cell line Animal  Injury References 
C2 2 month old C3Hmice Crush injury (Yaffe and Saxel, 1977) 
C2C12 2 month old C3Hmice Crush injury (Blau et al., 1985; Yaffe and Saxel, 1977) 
MM14 2 month old Balb/C - (Linkhart et al., 1980) 
L6 new-born rats - (Yaffe, 1968) 
L41 new-born rats - (Yaffe, 1968) 
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myogenic potential when reintroduced into mice (Asakura et al., 2002; Bhagavati and 
Xu, 2004; Seale et al., 2004b). Studies by Qu-Petersen et al. (2002) identified three 
populations of muscle-derived myogenic cells based on adhesion and proliferation 
characteristics. Utilizing the pre-plating technique developed by Rando and Blau (1994), 
the early pre-plate (EP) cells, the late pre-plate (LP) cells and a novel population of 
muscle-derived stem cells (MDSC) were fractionated and transplanted into Mdx mice 
to assess the efficiency of muscle regeneration. Although EP and LP cells showed a lack 
of contribution to regeneration, transplantation of MDSCs enhanced regeneration 
efficiency, dystrophin delivery and cell survival compared to EP and LP cell 
transplantation (Qu-Petersen et al., 2002). Further studies by Lee et al. (2000) isolated 
a population of muscle-derived stem cell called mc13, expressing CD34 and Bcl-2 
markers. Importantly, when mc13 cells were injected intravenously into Mdx mice, they 
facilitated muscle regeneration and partial restoration of dystrophin (Charge and 
Rudnicki, 2004; Lee et al., 2000). The CD45+:Sca-1+cells isolated from uninjured Pax7-/- 
muscle do not display myogenic capacity whereas CD45+:Sca-1+ cells from injured 
muscle gave rise to differentiated myoblasts along with the expression of MRFs such as 
MyoD and Myf5 (Seale et al., 2004b). However, when non-myogenic CD45+:Sca-1+ cells  
from uninjured Pax7-/- muscle were infected with retrovirus that express Pax7, the 
myogenic program is activated (Seale et al., 2004b). This emphasized that 
non-myogenic muscle-derived cells can undergo myogenesis following forced 
expression of transcription factor, Pax7.  
 
1.5.2 Non-muscle-derived myogenic cells 
Bone-marrow derived progenitor cells have been shown to display myogenic potential 
(Ferrari et al., 1998). These non-muscle derived cells have been shown to migrate to 
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the site of muscle injury and contribute to the repair process. Similarly, bone 
marrow-derived stem cells were shown both to contribute to muscle regeneration and 
to replenish the satellite cell pool in irradiation damaged muscle (Ferrari et al., 1998; 
LaBarge and Blau, 2002).  
 
Lastly, side population (SP) cells derived from muscle and other tissues displayed 
myogenic potential (Asakura and Rudnicki, 2002; Asakura et al., 2002). SP cells actively 
exclude Hoechst 33342 dye due to the expression of multi-drug resistance genes (a 
unique characteristic that permits separation by FACS®) and express hematopoietic 
markers, Sca-1 and CD45, but no detectable satellite cell markers, and readily undergo 
hematopoietic differentiation and not myogenic differentiation in vitro (Goodell et al., 
1996). However, when muscle SP cells are co-cultured with primary myoblasts, 
myogenic specification is induced (Asakura et al., 2002). Interestingly, muscle SP cells 
from Pax7-/- muscle not only undergo myogenic conversion when transplanted 
intramuscularly into regenerating muscle, but also give rise to satellite cells and 
myocytes (Asakura et al., 2002). Taken together, these studies have successfully 
identified various myogenic cells from different tissues which are molecularly distinct 
from satellite cells, and are capable of contributing to the repair and regeneration of 











Table 1.3: Summary of muscle-and non-muscle-derived cells capable of myogenesis 






 cells Muscle (Pax7-/-Injured muscle) (Seale et al., 2004b) 
mSP cells Muscle  (Asakura et al., 2002) 





) cells Muscle (Bhagavati and Xu, 2004) 
Non-muscle derived  
BM derived cells  Bone marrow (LaBarge and Blau, 2002) 
SP cells *Diverse adult tissues (Asakura and Rudnicki, 2002) 
BM-MSC Bone marrow (Bhagavati and Xu, 2004) 
BM progenitor cells Bone marrow (Ferrari et al., 1998) 
*SP cells were isolated from skeletal muscle, heart, brain, spleen, liver, kidney, lung, and small intestine. 
Abbreviations: mSP, muscle side-population; MSC, mesenchymal stem cells, MDSC, muscle-derived stem 
cells; EP, early pre-plate; LP, late pre-plate, BM, bone marrow; MSC, mesenchymal stem cells.  
 
1.6 Regulation of myogenesis by growth factors 
Besides the intrinsic molecular regulation of satellite cell myogenesis, growth factors 
and cytokines from the surrounding local or systemic environment have been shown to 
regulate myogenesis extrinsically by binding to their specific receptors. Growth factors 
are known to regulate every phase of myogenesis including activation (Allen et al., 
1995), proliferation (Schabort et al., 2009) and differentiation (Brack et al., 2008; Miura 
et al., 2006) in an autocrine, paracrine and endocrine manner. In this regard, satellite 
cells are ideally located in close proximity to interstitial cells, capillaries and adjacent 
myofibers that provide these extrinsic signals (Dhawan and Rando, 2005). The 
ligand-receptor binding of growth factors activates cellular signal transduction 
pathways that directly or indirectly control myogenesis. Three families of growth 
factors, Hepatocyte growth factor (HGF), Transforming growth factor-β (TGF-β) and 




1.6.1 Hepatocyte growth factor family 
Hepatocyte growth factor, also known as scatter factor (SF), was originally purified 
from rat platelets and known to stimulate DNA synthesis and proliferation in 
hepatocytes (Nakamura et al., 1984). Furthermore, HGF is known to participate in 
multiple activities including regeneration (renal and lung), tissue development and 
wound healing (Nakamura and Mizuno, 2010). HGF functions by binding to the c-met 
tyrosine kinase receptor and initiates cell intrinsic modifications (Birchmeier and 
Gherardi, 1998). Likewise, satellite cells also express c-met receptor indicating a 
possible role in myogenesis (Cornelison and Wold, 1997). Indeed, HGF and crushed 
muscle extract has been shown to activate quiescent satellite cells in monolayer 
cultures (Allen et al., 1995). Interestingly, blocking the activity of HGF in crush muscle 
extract with anti-HGF antibodies prevented quiescent satellite cell activity in mice, 
therefore activation was indeed induced by HGF (Tatsumi et al., 1998). HGF is 
expressed in uninjured and regenerating muscle and in the latter; the HGF mRNA 
transcript and protein levels were shown to increase during the initial stages of 
myogenesis (Tatsumi et al., 1998). Therefore, these studies show that the expression of 
c-met indicate that satellite cells is primed to activate in the presence of high HGF 
levels and that activation are definitely mediated by HGF. 
 
1.6.2 Transforming growth factor-β family 
TGF-β superfamily of proteins consists of more than 40 members such as the TGF-β, 
bone morphogenetic proteins (BMP) and growth differentiation factors (GDF). These 
members of TGF-β superfamily are known to regulate numerous cellular responses, 
including cell growth, cell-cycle progression, apoptosis, wound healing and 
differentiation (Vilar et al., 2006). It is commonly accepted that TGF-β proteins promote 
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proliferation and suppresses myogenic differentiation. There are three TGF-β members, 
TGF-β1, 2 and 3.  
 
TGF-β has been shown to suppress myogenic differentiation in the C2 myoblast cell line 
(Ewton et al., 1988), and promote proliferation and inhibit myogenic differentiation in 
C2C12 myoblast cell line (Schabort et al., 2009). Interestingly, TGF-β was shown to have 
no effect on either proliferation and differentiation in L6-A1 myoblast cell line (Ewton 
et al., 1988). Most importantly, addition of TGF-β1 to myofiber cultures indicated a 
reduction of satellite cells (Bischoff, 1990). These results clearly indicate the 
suppression of satellite cell proliferation in their natural niche. It is therefore clear that 
the role of TGF-β in myogenesis is not well defined. However, much of the study of the 
TGF-β superfamily has shifted towards the recently discovered Myostatin, a potent 
negative regulator of myogenesis (McCroskery et al., 2003).  
 
1.6.3 Fibroblast growth factor family 
Initially FGF was identified based on its ability to promote proliferation in 3T3 fibroblast 
cell line (Armelin, 1973). Further analysis identified at least 20 FGF members that signal 
by binding to a dual tyrosine kinase FGF receptor system which activates downstream 
signals leading to many cellular and physiological processes such as apoptosis, 
differentiation and wound healing (Barrientos et al., 2008). Satellite cells undergoing 
myogenesis are shown to express FGF receptors (FGFR), specifically FGFR 1 and 4, 
which suggest a role of FGF in myogenesis (Armand et al., 2006). In addition, FGF6 
levels have been shown to increase exclusively in myogenic cells (Armand et al., 2006). 
Injection of recombinant FGF6 proteins into CTX injured mice resulted in an 
accelerated muscle repair (Armand et al., 2003). Together, these results indicate that 
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FGF does play a role in myogenesis. However, the precise role of this growth factor 
family in proliferation and myogenic differentiation remains elusive. Analysis of FGF on 
the C2 myoblast cell line supported proliferation (Rando and Blau, 1994), however, 
studies with primary satellite cells showed only certain FGF isoforms supported 
proliferation. Moreover, FGF6-/- knock-out studies generated contradictory results. 
These results suggest that FGF6 has a dual function in myogenesis by stimulating either 
proliferation and differentiation in a FGF dose-dependent manner (Armand et al., 
2006). 
 
In summary, studies of growth factors on myogenic cell lines, primary satellite cells and 
myofibers have generated contradictory results. These contradictions are likely from 
the accumulated mutations in the cell lines and different culturing conditions in the 
primary and myofibers cultures.  
 
1.7 Age-related changes in skeletal muscle 
Myogenesis, mediated mainly by satellite cells, is a highly efficient process. However, 
aging in skeletal muscle leads to a rapid decline in this process. This decline in 
myogenesis is likely associated with the intrinsic and extrinsic changes due to an 
increase in age. Intrinsically, the activity of myogenic specific genes such as MRFs and 
telomere shortening could to be altered due to aging (Degens, 2007). Extrinsically, vast 
changes in aging muscle include the alterations in local and systemic environment 
ranging from the satellite cell niche, basal lamina and the secreted local and systemic 
factors. Finally, satellite cell numbers have been shown to be reduced in aging muscle 
(Shefer et al., 2006). Collectively, these age-associated intrinsic and extrinsic changes 
during aging in skeletal muscle are likely to be the cause of the reduced myogenesis. 
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1.7.1 Intrinsic changes 
Muscle specific genes such as MRF and Pax regulate myogenesis, therefore it was 
assumed that the reduced myogenesis in aging muscle is associated to the reduced 
levels and activity of MRF. Indeed, satellite cells isolated from aging muscle had fewer 
Pax7 expressing cells and when maintained in culture, underwent apoptosis (Collins et 
al., 2007). However, analysis of MRF levels, specifically the levels of MyoD and 
Myogenin, were contradictory (Brack et al., 2005; Dedkov et al., 2003). One intrinsic 
change that occurs in all somatic cells with the increase in age is telomere shortening 
(Bekaert et al., 2004). Severe shortening of the telomere below critical levels could 
result in apoptosis or in vitro senescence (Campisi, 1997). Studies of telomerase has 
shown that the telomerase activity is abolished during differentiation rather than aging, 
refuting the theory that an increase in age results in telomere shortening (O'Connor et 
al., 2009). Thus, it is not clear from such studies if telomere shortening directly impacts 
satellite cell function in aging muscle. The reduction of satellite cell numbers with age 
have also been suggested to contribute to the poor myogenesis in aging muscle. 
Indeed, quantification of satellite cell numbers have been shown to decrease with age 
(Renault et al., 2002; Shefer et al., 2006). Interestingly, although the reduction of 
satellite cells are observed, the myogenic capacity of the residual satellite cells in aging 
muscle is not altered (Collins et al., 2007). Furthermore, addition of FGF to aging 
satellite cells promoted efficient myogenesis (Shefer et al., 2006). Together, these data 
suggest that the inherent myogenic capability of satellite cells may not be altered with 
age and that changing the extrinsic factors, myogenesis could proceed. Lastly, the 
discrepancies from studies that aim to quantify the expressions of MRF and satellite 
cell numbers could stem from the different myofibers analyzed, age of animals, animal 
species, severity of the induced injury and the lack of quiescent satellite cell-specific 
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markers (Brack and Rando, 2007). 
 
1.7.2 Extrinsic changes 
Aging in skeletal muscle leads to vast changes in the satellite cell niche, local and 
systemic environment (Fig. 1.3). These changes to aging muscle are known as 
sarcopenia, a process that is typified by reduced muscle mass (atrophy) and strength 
with the accumulation of lipids and fibroblasts (Solomon and Bouloux, 2006). 
Collectively, these age-associated extrinsic changes in sarcopenic muscle ultimately 
affect the regenerative capacity of satellite cells.  
 
1.7.2.1 Satellite cell niche 
Satellite cells in the niche are located in the micro-environment between the overlaying 
basal lamina and the underlying myofiber. The myofibers serve as the support structure 
for the satellite cells and provide signals for myogenesis whereas the overlaying basal 
lamina separates the satellite cells from interstitial cells and fibroblasts to regulate the 
influx of secreted growth factors from the ECM (Gopinath and Rando, 2008). Secreted 
signals provided by myofibers are known to maintain satellite cell quiescence until 
activated, however these signals are yet to be identified. Alterations in the satellite cell 
niche in aging skeletal muscle results in reduced cross-sectional area with a thicker 
basal lamina (Brack and Rando, 2007). Generally, a disruption or alteration to the 
natural niche of stem cells results in the disruption of stem cell activity. Similar studies 
have shown that aging myofibers have an impaired activation and proliferation of 
satellite cells through the suppression of Notch signaling (Conboy et al., 2003). In aging 
muscle, the expression of Notch receptor in satellite cells remains constant; however 
myofibers fail to express Delta ligand which results in reduced Notch signaling thus 
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negatively impacting satellite cell myogenesis (Conboy et al., 2003). The basal lamina is 
composed of collagen type 4, perlecan, laminin, entactin, fibronectin, glycoproteins 
and proteoglycans (Sanes et al., 1978). Laminin and fibronectin, both components of 
the basal lamina, have been shown to promote proliferation in MM14 myoblasts 
(Ocalan et al., 1988). Through the progressive accumulation of toxic-by products and 
collagen, the basal lamina thickens with the increase in age, in addition, electron 
microscopic studies have indicated an extra lamina that intrudes between the 
myofiber-satellite cell interspace (Gopinath and Rando, 2008). The consequence of 
these changes renders the satellite cell less sensitive to the paracrine factors secreted 
from the myofibers and cells from the local and systemic environment. Satellite cells 
are, therefore less responsive to activating signals (HGF), proliferating signals (TGF-β) 
and differentiating signals (FGF). Thus, changes to the niche impacts negatively on 
myogenesis. 
 
1.7.2.2 Local and systemic environment 
Growth factors secreted by cells in the local and systemic environment regulate every 
phase of myogenesis (section 1.6). Therefore, changes to these growth factors during 
aging would likely affect myogenesis. TGF-β, a growth factor that is known to promote 
fibrosis and impede myogenic differentiation has been shown to be elevated in aging 
muscles (Carlson et al., 2009; Li and Fan, 2004). This increased level of TGF-β could be a 
compensation effect because of the less responsive aging satellite cells. Furthermore, 
HGF and FGF extracts from crushed aging muscle were less capable of activating both 
young and old myoblasts (Mezzogiorno et al., 1993). These results emphasize that the 
aging environment of muscles are less supportive of effective myogenesis. Therefore, 
the failures of satellite cells to interact with these regulatory factors or an imbalance of 
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negative to positive factors in aging muscles are among the cause of impaired 
myogenesis. The systemic environment provides another source of myogenesis 
regulating factors. Evidence for such regulation comes from two kinds of heterochronic 
studies. Earlier studies extracted whole muscles from young and old rats and grafted 
these into old and young host rats, respectively (Carlson and Faulkner, 1989). Results 
indicated that the success of the muscle graft was dependent on the age of the host rat 
rather than the muscle extract. Following this parabiotic study, where the circulatory 
system of young and old mice was linked to assess the success of myogenesis with the 
altered systemic environment was conducted. Indeed, old mice received young serum 
factors recovered effectively from muscle induced injury, whereas the young mice 
received the old serum factors had a reduced muscle repair (Conboy et al., 2005). In 
support of this study, serum from young mice was able to stimulate myogenesis 
whereas serum from old mice impeded myogenesis, in myoblast cultures (Brack et al., 
2007). However, the factors in old serum that negatively impact myogenesis were not 
identified. In a separate study, both growth factors TGF-β and IGF were identified in 
serum from old mice and were determined to be elevated (Brack and Rando, 2007; 
Carlson et al., 2009). Moreover, Wnt proteins were determined to be elevated in serum 
from old mice which resulted in elevated Wnt signaling, lead to poor myogenesis and 
increased fibrosis (Brack et al., 2007). Nevertheless, the accumulated data established 
that satellite cell activity is regulated by local and systemic factors in a paracrine 
manner and most importantly, the reduced myogenesis by satellite cells in aging 





























Fig. 1.3: Extrinsic environment of young and aging skeletal muscle 
Extrinsic changes from young (A) and aging muscle (B) impacts satellite cell (SC) function. Satellite cells interact intimately with the supporting myofibers and the basal lamina in the satellite cell niche. In young muscle (A), paracrine and autocrine factors (Wnt, 
HGF, FGF, TGF-β, etc) secreted by fibroblast (red arrow), macrophages (cells of the immune system, green arrow), myofiber (double-headed arrows) and interstitial cells in the ECM modulate satellite cell activity. Furthermore, an influx of positive and negative 
systemic factors (curved arrows) from the circulatory system (A) further alters the extrinsic environment that impacts satellite cell function. In aging muscle (B), the basal lamina thickens due to collagen deposits from fibroblasts (black arrow). The 
encapsulating lamina, which envelopes satellite cell, renders satellite cell less susceptible to autocrine and paracrine signals from fibroblasts (red arrow), macrophage (green arrow) and the supporting myofiber (yellow double-headed arrows). Moreover, it has 
been suggested that high levels of negative factors such as Wnt and TGF-β from the circulatory system in aging muscle contribute to impaired regeneration. Further alterations in aging muscles (B) include an increase in adipocyte number, reduced myonuclei 
number, increase in fibroblast number and reduced muscle cross-sectional area. Collectively, these changes ultimately modify the properties of satellite cell in aging muscle and are hallmarks of aging sarcopenic muscle.
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1.8 The Wnt family of signaling proteins 
Wnt proteins are a class of glycosylated, secreted, signaling and in certain isoforms, 
palmitoylated signaling proteins (Willert et al., 2003). Wnt is coined from the 
combination of Drosophilia Wingless (Wg) and mouse Int-1 genes. There are three 
classes of Wnt signaling: a) the well characterized canonical/β-catenin dependent 
pathway and the poorly understood non-canonical/β-catenin independent pathways 
namely, b) calcium (Ca2+) and c) planar cell polarity (PCP) pathways that leads to 
activation of distinct genes (Huelsken and Behrens, 2002). The outcome of the 
expressed genes has been shown to play a vital role in a variety of cellular processes 
such as proliferation, differentiation, apoptosis, orientation, cell senescence and 
migration (Maiese et al., 2008). More recently, Wnt signaling has been shown to be 
vital in myogenic differentiation and myogenic lineage specification. 
 
1.8.1 Wnt proteins 
Currently, there are at least 21 identified Wnt isoforms with molecular weight of 
39-46 kDa (Maiese et al., 2008). Wnt proteins contain a conserved distribution of 
cysteines and a signal sequence (Kikuchi et al., 2007). Furthermore, these proteins 
are glycosylated and palmitoylated (or lipidated) and as a result are mostly insoluble 
(Kikuchi et al., 2007). This high degree of insolubility makes Wnt proteins difficult to 
purify and therefore difficult to characterize. In addition, the level of secretion of Wnt 
proteins is known to be very low, therefore it is difficult to obtain sufficient quantities 
for analysis. The difficulty to obtain purified Wnt proteins leads to alternative 
methods to assess the effect of Wnts, such as conditioned media and co-culturing. 
Conditioned media are generated initially by culturing transfected cells (with Wnt 
containing construct) to secrete the desired Wnts followed by utilizing the 
Wnt-conditioned media to culture the cells of interest. Co-culturing involves culturing 
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of transfected cells simultaneously with the cells of interest which offer a constant 
supply of secreted Wnt. Both methods generate media with high levels of secreted 
Wnts to monitor the effect on the cells of interest. However, results utilizing these 
methods have been contradictory to the results generated with purified Wnts. 
Presently, only Wnt3a and Wnt5 proteins are successfully purified from conditioned 
media (Mikels and Nusse, 2006; Willert et al., 2003). The effect of the purified Wnt3a 
was shown to promote hematopoietic stem cell proliferation and suppress 
differentiation, conversely, Wnt3a-conditioned media from mouse L fibroblast cells 
promoted differentiation (Willert et al., 2003). Furthermore, analysis of canonical vs. 
non-canonical pathway initiated by the purified Wnt5a was contradictory to 
conditioned media (Mikels and Nusse, 2006). These results suggest that other factors 
in the conditioned media or co-culture secreted by the transfected cells could cause 
these discrepancies. Therefore, these results highlight the importance of purified 
proteins to analyze the role of Wnt proteins.  
 
1.8.2 Canonical vs. non-canonical Wnt signaling 
The canonical/β-catenin dependent pathway is activated by binding of Wnt protein 
to the Frizzled receptor and low-density lipoprotein receptor-related protein-5/6 
(LRP5/6) co-receptor. In the absence of Wnts, disheveled protein is inactivated and 
as a result, a β-catenin destruction complex is formed, comprised of Axin, glycogen 
synthase kinase-3β (GSK-3β), Casein Kinase-1 (CK1) and Adenomatous polyposis coli 
(APC) (Jin et al., 2008). In this complex, β-catenin is phosphorylated multiple times at 
serine or threonine residues 41, 37 and 33, firstly by GSK-3β followed by the 
phosphorylation by CK1 at serine 45 (Huelsken and Behrens, 2002). Subsequently, 
the phosphorylated β-catenin is ubiquitinated by β-transducin repeat-containing 
protein (βTrCP) and degraded by the large protease, proteosome (Fig. 1.4A). 
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Therefore, no Wnt-related genes are activated. Canonical/β-catenin dependent 
pathway is activated with Wnts binding to the Frizzled receptor (Fig. 1.4B). This 
ligand-receptor interaction activates Dsh and prevents the formation of β-catenin 
destruction complex. This in turn prevents β-catenin phosphorylation by inhibiting 
GSK-3β. Stable cytosolic β-catenin accumulates in the cytoplasm and eventually 
translocates into the nucleus, complexes with T-cell factor/lymphoid enhancer factor 
(TCF/LEF) transcription factor and lead to expression of Wnt target genes which 
include MyoD and Myogenin (Jin et al., 2008). The poorly understood 
non-canonical/β-catenin independent pathways include the calcium (Ca2+) and planar 
cell polarity (PCP) pathways. In the cell polarity pathway, Wnt binds to the receptor 
without LRP5/6 co-receptor and activates JNK via the activation of GTPase Rho and 
directs cytoskeletal re-organization. Rearrangement of the cytoskeletal proteins can 
also be mediated directly by the activation of Rho-associated kinase (ROCK). This 
pathway has been shown to play a role in migration (Cadigan and Nusse, 1997). The 
activation of Ca2+ pathway leads to the production of intracellular calcium. Binding of 
Wnt to the Frizzled receptor activates phopholipase C (PLC) and protein kinase C (PKC) 
possibly through G-protein. Activation of PLC leads to the accumulation of calcium 
and can activate phosphatase calcineurin which dephosphorylates NF-AT (Huelsken 
and Behrens, 2002). The de-phosphorylated NF-AT translocates into the nucleus and 
activates Ca2+ pathway genes. It is clear that the non-canonical pathway has only 
been partially defined; therefore further studies are required to define the 
interactions of proteins in the non-canonical pathway. Although these studies have 
partially clarified the mechanism of Wnt signaling and the proteins involved, but due 
to the lack of purified active Wnt proteins, it has been difficult to verify which Wnt 































Fig. 1.4: The canonical/β-catenin dependent Wnt signaling  
Activation of canonical Wnt signaling results in the target gene expression via β-catenin. In the 
absence of Wnt, β-catenin is phosphorylated by GSK-3β, CK1 in the β-catenin destruction complex, 
ubiquitinated by βTrCP and actively degraded by the proteasome in the cytoplasm (A). Activation of 
the canonical Wnt signaling leads to the accumulation of β-catenin (B). Wnt binds to the Frizzled 
receptor, activates Dsh and prevents the formation of β-catenin destruction complex and accumulates 
in the cytoplasm. β-catenin translocates into the nucleus, associates with TCLF/LEF and activates 
target genes. Expression of target genes have been shown to play a vital role in numerous cellular 
processes such as proliferation, differentiation, apoptosis, orientation, cell senescence and migration 
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The purified Wnt3a has been shown to signal through the canonical pathway, verified 
by the accumulated cytoslic β-catenin (Willert et al., 2003). Interestingly, Wnt5a was 
initially classified as a canonical Wnt protein (He et al., 1997), however, recent 
studies have shown that Wnt5a signals via canonical pathways only in the presence 
of an appropriate receptor, Frizzled 4 (Mikels and Nusse, 2006). Together, both 
studies have shown the importance of obtaining pure Wnt proteins to determine its 
role and the signaling pathway it induces. 
 
1.8.3 Wnt signaling in myogenesis 
A wealth of data has been generated documenting the influence of Wnts on 
embryological development. Wnt5a has been shown to inhibit secondary axis 
formation in Xenopus embryos whereas Wnt1 class induces this formation (Li et al., 
2006). Furthermore, Wnts have an effect on myogenesis during embryogenesis. 
Subsequent studies have led to the understanding of Wnt proteins on adult tissues. 
In the complicated process of cardiac wound healing in the heart, it has been shown 
that Wnt10b and Wnt8a are up-regulated while Wnt7b is down-regulated after 
myocardial infarction (Barandon et al., 2003).  
 
Traditionally, it was accepted that Wnt proteins promote proliferation in a variety of 
stem cell cultures, however in isolated myoblasts, Wnts were shown to promote 
myogenic differentiation. Numerous studies have generated adequate evidence that 
Wnt signaling play a role in myogenic differentiation, specification and lineage 
progression. Early studies have indicated that Wnt signaling by Wnt3a promotes 
myogenesis in P19 embryonal carcinoma stem cells by up-regulating MyoD and 
Myogenin (Ridgeway et al., 2000). Later, β-catenin, a down-stream target of Wnt 
signaling, was shown to interact directly with MyoD and enhance MyoD 
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transcriptional activity (Kim et al., 2008; Petropoulos and Skerjanc, 2002). Analysis of 
myoblast cultures revealed that the induction of myogenic differentiation coincides 
with the up-regulation of canonical Wnt signaling and by suppressing this pathway 
with secreted frizzled receptor protein-3 (sFRP3) antagonist, myogenesis was 
reduced (Brack et al., 2008). This induction of myogenic differentiation requires the 
correct temporal down-regulation of the proliferation regulating Notch pathway and 
the up-regulation of Wnt signaling. However, injection of Wnt3a to the regenerating 
muscles in mice had a detrimental effect on muscle repair which could arise from the 
early up-regulation of Wnt signaling by the injected Wnt3a that initiated premature 
differentiation rather than proliferation by the Notch pathway. Furthermore, an 
increase in Wnt3a mRNA transcript levels were observed which coincide with the 
up-regulation of Wnt signaling (Brack et al., 2008). Finally, non-myogenic CD45+ cells 
derived from muscles up-regulated Pax7 and MyoD in media containing a Wnt5a, 5b, 
7a and 7b (Polesskaya et al., 2003). Collectively, data from these studies indicate that 
Wnt signaling regulates myogenic differentiation, specification and lineage 
progression. 
 
1.8.4 Wnt signaling in aging muscle 
Aging in skeletal muscle brings about vast changes that alter satellite cell myogenesis 
(section 1.7). Recently, parabiotic studies indicated that systemic factors impact 
satellite cell function and following exposure of old mice to a youthful environment, 
aging satellite cells are rejuvenated and undergo effective myogenesis (Conboy et al., 
2005). In support of this hypothesis, muscle sections from heterochronic mice pairs 
showed a reduced collagen deposition in old muscle with an increase in proliferation, 
verified by the BrdU incorporation experiment (Brack et al., 2007).  
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The reduced myogenic capability in aging muscle is accompanied by the increase in 
fibroblast number. Utilizing a fibroblast marker, ER-TR7, isolated myoblast cultures 
showed an increase in ER-TR7+ cells in aging myoblasts (Brack et al., 2007). Therefore, 
this age-related decline in satellite cell myogenesis is also accompanied by a 
myogenic to fibrotic lineage conversion. The effect of serum components were also 
analyzed for regulating myogenesis on isolated myoblasts from young and old mice. 
Results showed that young serum promoted myogenesis in old myoblasts, whereas 
old serum impeded myogenesis in young myoblasts (Brack et al., 2007). It was 
speculated that the up-regulation of Wnt signaling contributed to the reduced 
myogenesis. Indeed, analysis of the downstream targets of Wnt signaling such as 
Axin and β-catenin, in old myoblasts were increased significantly (Brack et al., 2007). 
Incubation of young myoblasts with serum from old mice showed reduced 
myogenesis therefore it is likely that Wnt proteins are found in serum. This was 
verified by Wnt depletion experiment. In the Wnt depletion experiment, two fusion 
proteins with Frizzled receptor on each were constructed (Brack et al., 2007). The 
fusion proteins were incubated with the serum from old mice and followed by 
culturing with myoblasts. The result showed an improvement in myogenesis. In vitro 
and in vivo assays showed that the incubation or injection of Wnt3a contributed to 
this impaired myogenesis. Together, these series of experiments showed that the 
up-regulation of Wnt signaling by Wnt3a in the serum of the circulatory system was 
the contributing factor in the reduced myogenesis and the increase in myogenic to 
fibrotic lineage conversion.  
 
The increase in adipocytes is another hallmark of aging muscle. The balance between 
myogenic and adipogenic lineage was shown to be controlled by Wnt signaling via 
Wnt10b, however this balance is lost during aging. Up-regulation of Wnt signaling by 
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Wnt10b was shown to be crucial to inhibit myogenic to adipogenic lineage 
conversion by mechanical stretching concurrent with the increase in Wnt10b mRNA 
transcript levels in C2C12 cells (Akimoto et al., 2005). However, in aging muscle, this 
increase in Wnt10b mRNA transcript levels was linked to cause a myogenic to 
adipogenic lineage conversion with age (Taylor-Jones et al., 2002). Interestingly, 
Wnt10b-/- knock-out mice demonstrated effective myogenesis in young mice (Vertino 
et al., 2005). Further studies indicated a compensation effect by Wnt7b that 
contributed to the successful myogenesis, however in aging myoblasts, this 
compensation was absent and in fact show a down-regulation of Wnt10b and 5b 
(Vertino et al., 2005). Therefore, results from these studies indicate that regulation of 
adipogenesis by Wnt signaling via Wnt10b has not been clearly defined and that 
many discrepancies in data exist. Moreover, it is clear from the knock-out studies 
that other classes of Wnt proteins do play a role in regulating lineage alteration. 
However due to the lack of purified Wnt proteins it is difficult to verify which class of 
Wnts contributes to the reduced myogenesis and the increased lineage alteration 
with age. 
 
1.9 Objectives of the current study 
Canonical Wnt signaling has been demonstrated to gradually increase during 
myogenesis which corresponds with the gradual rise in mRNA Wnt transcripts, 
specifically Wnt3a (Brack et al., 2008). However, due to the previous lack of Wnt 
antibodies, quantitative analysis of relevant Wnt proteins during myogenesis has not 
been determined. Therefore, the aim of the current study was to: 1) analyze Wnt 
protein expression, specifically Wnt3a, 7 and 10b isoforms, during proliferation and 
differentiation in early and late passage C2C12 cells, utilizing the currently available 
antibodies. Both cytosolic and secreted forms of Wnts were quantified, 2) Determine 
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the effect of the secreted Wnts in the conditioned media from the early and late 
passage C2C12 cells on late and early passage C2C12 cells, respectively. We 
hypothesise that secreted combinations of Wnt3a, 7 and 10b isoforms from early 
passage C2C12 cells can improve myogenic differentiation in late passage C2C12 cells, 
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ABSTRACT 
Satellite cells are muscle progenitor cells responsible for skeletal muscle maintenance 
and repair. The capacity of these progenitor cells to differentiate into myotubes 
decreases with age; as a result, muscle repair in an aging organism is characterized 
by fibrosis and lipid accumulation rather than myogenesis. Recent studies have 
suggested that the Wnt family of signaling proteins is pivotal in regulating cell fate, 
proliferation and differentiation, during aging. Wnt3a is known to induce fibrogenesis 
and Wnt10b adipogenesis, whereas Wnt7 induces myogenesis.   
 
In the current study, we aim to determine the cytosolic expression and the secreted 
profiles of the three key Wnt isoforms, Wnt3a, 7 and 10b, during myogenesis of early 
and late passage C2C12 myoblasts. Late passage myoblasts were seen to have a 
higher proliferative rate, as well as a higher expression of GAPDH, α-tubulin and 
surprisingly, MyoD, than early passage cells. However, myogenic capability was 
reduced in the late passage cells as indicated by both the lack of myotube 
appearance and Myogenin expression. Analysis of Wnt3a showed higher levels of 
cytosolic protein in late vs. early passage cells at all-time points analyzed, suggesting 
an elevated fibrogenic predisposition. Secreted levels of Wnt7 were maintained at 
higher levels in early vs. late passage cells at day 1 and 3. The rapid decreased 
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secretion of Wnt7 in late passage cells suggests a possible mechanism for the 
inefficient myogenesis observed. Lastly, Wnt10b cytosolic levels were constantly 
elevated in early versus late passage cells. Analysis of the secreted versus cytosolic 
ratio in Wnt7 levels revealed a more rapid decline in late passage versus early 
passage cells during differentiation, suggesting a decreased ability to promote 
myogenesis. Taken together, increased cytoslic production of Wnt3a with decreased 




Satellite cells are resident, quiescent skeletal muscle stem cells located in a niche 
between the sarcolemma and basal lamina along muscle fibers (Charge and Rudnicki, 
2004; Mauro, 1961). Satellite cells are characterized their anatomical location, 
molecular marker expression and function. In their quiescent state, they express 
markers such as Pax7, M-cadherin, c-met, SM/C-2.6 and CD34 (Beauchamp et al., 
2000; Fukada et al., 2004; Hollnagel et al., 2002; Tatsumi et al., 1998; Zammit et al., 
2006). When new myonuclei are required to facilitate hypertrophy or repair, satellite 
cells exit quiescence, begin to proliferate, differentiate and eventually fuse with each 
other (or with existing myofibers), to form new myotubes (Burdzinska et al., 2008). 
The up-regulation of myogenic regulatory factor (MRF) expression such as MyoD, 
Myf5, Myogenin and Mrf4 is central to this process (Fuchtbauer and Westphal, 1992; 
Holterman and Rudnicki, 2005). In addition, the repair process is accompanied by 
satellite cell self-renewal, ensuring that after repeated rounds of regeneration, the 
stem cell population is maintained (Kuang et al., 2007). 
 
Following a severe injury (such as shearing) the regenerative potential of satellite 
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cells is compromised (Charge and Rudnicki, 2004). This type of injury causes the 
complete rupture of the basal lamina, necrosis of myofibers and subsequent collagen 
deposition that result in scar formation and hampers satellite cell function. On the 
other hand, aging muscle is characterized by muscle atrophy due to poor 
maintenance by satellite cells, a condition known as sarcopenia (Solomon and 
Bouloux, 2006). Numerous studies suggest this age-related lack of regeneration is 
due to a decline in satellite cell function, most likely associated with the altered 
intrinsic activities of MRF and low satellite numbers (Conboy et al., 2005; Shefer et al., 
2006).  
 
The extrinsic environment is also known to change with age in skeletal muscle. Local 
(the satellite cell niche and myofiber) and systemic (changes in the circulating serum 
factors) conditions change which directly impact satellite cell function. With age the 
satellite cell niche and the myofiber are altered with the thickening of the basal 
lamina and a further layer of basal lamina between the myofiber-satellite cell 
interspace. This leads to the loss in sensitivity of satellite cells to paracrine and 
endocrine factors secreted by the cells of the extracellular matrix (ECM): infiltrating 
neutrophils, monocyte, macrophages and myofiber itself (Gopinath and Rando, 
2008). Essential growth factors such as hepatocyte growth factors (HGF), fibroblast 
growth factor (FGF) and transforming growth factor-beta (TGF-β) are known to 
enhance the activation and proliferation of satellite cells (Schabort et al., 2009; 
Tatsumi et al., 1998; Yablonka-Reuveni et al., 1999). In addition, an increase in 
adipocyte and fibroblast numbers within aging muscle has been observed.  
 
Systemic changes, specifically serum factors, have been shown to modify satellite cell 
functions and decrease myogenic lineage progression. Parabiotic studies, where the 
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circulatory system of old and young mice were linked, revealed that serum factors 
within the circulatory system of a young mouse were able to rejuvenate the 
regenerative capacity of the satellite cells in skeletal muscle of the old mouse 
(Conboy et al., 2005). Results showed that satellite cells in young mice had a reduced 
myogenic differentiation capability and trans-differentiated to acquire a fibrogenic 
lineage when exposed to the serum from old mice (Brack et al., 2007). Further 
analysis revealed that a Wnt protein, specifically Wnt3a, was a pivotal mediator of 
the observed phenotypic change. This myogenic-to-fibrogenic conversion was 
reflected by an increased collagen deposition thereby further promoting the fibrotic 
environment. 
 
TGF-βs are known inhibitors of myogenic differentiation and recently, elevated 
TGF-β1 levels were also reported to be found in serum of aging muscle (Carlson et al., 
2009). Elevated Wnt and TGF-β levels in serum of aged muscles could both have a 
deleterious effect on muscle repair and regeneration. Taken together, the parabiotic 
pairing technique suggests that the extrinsic factors from the local and systemic 
environment changes with age; this change in turn directly impacts satellite cell 
function and lineage progression. Interestingly, these results also indicate that the 
resulting intrinsic changes with age are indeed reversible (Brack et al., 2007). 
 
Wnt signaling is known to play a key role in myogenic differentiation as seen by the 
fact that a regulated temporal switch from Notch to Wnt signaling is required for 
myogenesis (Brack et al., 2008). Moreover, a sub-population of CD45+ cells (with 
hematopoietic potential) from injured muscle can adopt a myogenic lineage in the 
presence of Wnts5a, 5b, 7a, and 7b mix (Polesskaya et al., 2003). Satellite cells are 
also known to trans-differentiate more readily into an adipogenic lineage with age 
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which may also be mediated by changes in serum factors and possibly by the 
presence of elevated Wnt10b levels (Asakura et al., 2001; Vertino et al., 2005). In 
aging muscle, elevated levels of certain Wnts can activate the Wnt pathway 
prematurely leading to impaired myogenesis. The expression of Wnt proteins at the 
mRNA level has been well documented during differentiation of myoblasts; however, 
due to the previous lack of commercial antibodies, the Wnt protein expression has 
not been determined to date. Therefore, the aim of his study was to determine the 
levels of cytosolic and secreted Wnt proteins (specifically Wnt3a, 7 and 10b) during 
proliferation and differentiation of early and late passage C2C12 cells. 
 
2.2 MATERIALS AND METHOD 
2.2.1 Materials 
Low passage C2C12 cells were kindly donated by the Cape Heart Centre (University of 
Cape Town). Specialized reagents to sub-culture, maintain and differentiate C2C12 
cells are trypsin-EDTA, horse serum (Sigma), fetal bovine serum (Gibco) and 
Penicillin-streptomycin (Highveld Biologicals). Dulbecco’s Modified Eagles Medium 
and L-glutamine were from Sigma (South Africa). C2C12 cells were cultured in T75, 
T25 or 6 well plates from Nunc (Denmark) and maintained in an Innova CO-170 
CO2-incubator (New Brunswick). C2C12 cells were monitored with Moticam 2300 










Table 2.1: Individual reagents for growth and differentiation medium 
Reagents Percentage (%) Volume  
#Fetal calf serum  10 50 
*Horse serum 1 5 
Penicillin-Streptomycin (Penstrep) 2 10 
L-glutamine  2 10 
Dulbecco's Modified Eagles Medium (DMEM) - 430 
Growth medium constitutes 
#
fetal calf serum, penicillin-streptomycin, L-glutamine and DMEM. For 
differentiation medium, fetal calf serum was substituted with *horse serum. The growth and 
differentiation medium were aliquoted into 50 ml falcon tubes and stored at 4 °C. 
 
General reagents for buffers (Table 2.1) and experiments are NaCl, Potassium 
ferricyanide, Potassium ferrocyanide, MgCl2, phosphoric acid, Sodium dodecyl sulfate 
(SDS), Ammonium persulfate, glycine, glycerol, bromophenol blue, Polyethylene 
glycol (PEG) 20 000, Potassium chloride (KCl), Na2HPO4, KH2PO4, gluteraldehyde, 
Mercaptoethanol and citric acid monohydrate were purchased from Merck. Tris-HCl 
purchased from Melford, Formaldehyde and methanol from BDH, ethanol from Illovo 
(South Africa) and Tween 20 from Sigma (South Africa). 
 
Table 2.2: General buffers  
Buffers pH Application 
Phosphate-buffered saline (PBS) 7.4 Cell culture, *ICC 
Citrate/phosphate buffer 6 #SA-β-gal assay 
Tank buffer  - SDS-PAGE 
Transfer buffer  - Western blot 
Tris-buffered saline (TBS) 7.5 Western blot 
*Immunocytochemistry; 
#
 Senescence-associated β-galactosidase 
 
Specialized reagents for senescence-associated β-galactosidase (SA-β-gal) assay 
Bradford assay, SDS-PAGE, western blotting and Immunocytochemistry (ICC) are 
5-Bromo-4-Chloro-3-indoyl-β-D-galactopyranoside (X-gal) (Bioline, BIO-37035), 
Coomassie brilliant blue G-250 (Sigma, 27815), ovalbumin (Roche), dialysis tubes 
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(Sigma, D9652), acrylamide and bisacrylamide (Sigma), pegGOLD protein marker-V 
(peqLAB), RIPA buffer (containing: 50 mM Tris-HCl, pH 8.0; 150 mM sodium chloride; 
1.0% Igepal; 0.5% sodiumdeoxycholate; 0.1% sodium dodecyl sulfate), protease 
inhibitor cocktail (containing: AEBSF, Aprontinin, Bestatin hydrochloride, E-64, 
Leupeptin, Pepstatin A, P8340), nitrocellulose membrane (Hybond-C™ Extra, 
Amersham), Ponceau S (Fluka, 81460), donkey serum (Sigma, D9663), primary and 
secondary antibodies (Table 2.3), donkey anti-mouse-FITC, Hoechst (Sigma, B2261), 
phalloidin-TRITC (Sigma, P1951) and ECL kit (Immun-Star™ WesternC™ 





Table 2.3: Dot blot optimized primary and secondary antibodies for western blot analysis 









MF 20, Hybridoma Bank 
554130, BD Bio (5.8A) 
Myogenin  Mouse monoclonal ~36 1/400 sc-12732, Santa Cruz (F5D) 
Wnt3a Rat monoclonal ~55 1/3200 sc-80457, Santa Cruz (YY-7) 
Wnt7a/b Rabbit polyclonal ~55 1/800 sc-32865, Santa Cruz (H-40) 










sc-5286, Santa Cruz (B-7) 
2118, Cell Signaling, (14C10) 
Secondary antibody Dilution Company 
Polyclonal rabbit anti-mouse Immunoglobulins/HRP 1/16000 P-0260, DAKO 
Polyclonal goat anti-rabbit Immunoglobulins/HRP 1/4000 P-0448, DAKO 
Polyclonal rabbit anti-rat IgG/HRP 1/40000 A9542, Sigma  
The molecular weights of target antigens were determined via western blotting (section 2.2.7). 
Primary antibodies were optimized with dot blot analysis prior western blotting (section 2.2.6). *Used 




2.2.2 Cell culture 
Early (P13) and late passage (P33) murine C2C12 cells were maintained in growth 
medium containing Dulbecco’s Modified Eagle’s Medium (Sigma) supplemented with 
10% Fetal bovine serum (Gibco), 2 mM L-glutamine (Sigma) and 1% 
Penicillin/Streptomycin (Highveld Biological) in an Innova® CO-170 CO2-incubator 
(New Brunswick) at 37 °C, 5% CO2. Cells were induced to differentiate when 80% 
confluent by changing growth medium with differentiation medium containing of 
Dulbecco’s Modified Eagle’s Medium (Sigma) supplemented with 1% horse serum 
(Sigma), 2 mM L-glutamine (Sigma) and 1% Penicillin/Streptomycin (Highveld 
Biological). Differentiation was monitored and images captured at days 0, 1, 3, 5 and 
7 with a Moticam 2300 camera (Motic) mounted on Olympus U-MCB Provis 
microscope.  
 
2.2.3 Senescence-associated β-galactosidase assay 
Early and late passage C2C12 cells were plated into 6 well plates (50 000 cells/well). 
Upon reaching ~40% confluency, cells were washed with PBS, fixed with 2% 
formaldehyde: 0.2% gluteraldehyde for 8-10 minutes, washed with PBS and stained 
with fresh X-gal stain solution: 1 mg/ml X-gal, 40 mM citrate/phosphate buffer, 300 
mM NaCl, 5 mM Potassium Ferricyanide, 5 mM Potassium Ferrocyanide, 2 mM MgCl2 
for 16 hours at 37°C. Stained cells were washed with PBS, viewed with an Olympus 
U-MCB Provis microscope and images captured with a Moticam 2300 camera (Motic). 
Images were analyzed using Image J software and percentage senescence 
determined as the number of stained cells divided by the total number of cells in 




2.2.4 Analysis of proliferation 
To determine the proliferation potential of early and late passage C2C12 cells, we 
plated 750 000 cells into T75 flasks containing growth medium (day 0). Cells were 
trypsinized on days 1 and 2, and counted using a haemocytometer. 
 
2.2.5 C2C12 protein lysate and conditioned media preparation 
Early and late passage C2C12 cells were harvested at different time points (day 0, 1, 3, 
5 and 7), detached with trypsin-EDTA, lysed in RIPA buffer (Sigma) and protein 
inhibitor cocktail (Sigma, P8340), and sonicated for 5 seconds in eppendorf tubes 
submerged in ice. For the conditioned media (CM) preparation, early and late 
passage cells were plated into T25 flasks in ~10ml growth medium and upon reaching 
80% confluency, the growth medium was collected (day 0, control) and cells were 
induced to differentiate by changing to differentiation medium and subsequently 
collected at day 1, 3 and 5. All collected CM were stored at -20 °C. To concentrate the 
diluted CM, CM were transferred into dialysis tubing (Sigma) and concentrated 
against PEG 20 000 (Merk) to ~500μl. Prior to western blotting, total protein lysates 
and CM concentrations were done according to Bradford (1976).  
 
Briefly, a standard curve was constructed from an ovalbumin (Roche) standard 
protein stock with a range of chosen concentration, 0 to 40 μg/ml (Fig. 2.1). A 
mixture of Bradford dye with the desired ovalbumin concentration for each 
concentration points was prepared and absorbance reading at 595 nm was taken 
with a Biomate 3 spectrophotometer (Thermo Scientific). The unknown 
concentrations of the total lysates and CM were determined with the linear 
regression formula (Fig. 2.1). The protein lysates were probed for the transcription 
factors MyoD, Myogenin and the cytosolic Wnt3a, 7 and 10b, whereas the CM was 
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probed for the secreted form of Wnt3a, 7 and 10b by western blotting. 
 
 
Fig. 2.1: Ovalbumin Bradford standard curve  
Ovalbumin standard curve was constructed to determine the unknown concentrations of C2C12 cell 
lysates and the conditioned media. Ovalbumin protein was made up in d.H2O to a concentration of 
1μg/ml and subsequently aliquoted at different volumes according to the desired concentrations (0 – 
40 μg/ml), Bradford (Coomassie brilliant blue G-250) dye were added and made up to a final volume 
of 1 ml with d.H2O in Eppendorfs. The protein-dye mixtures were transferred into plastic curvettes and 
absorbance readings taken at 595 nm with a spectrophotometer. A linear regression formula was 
determined (y = 0.0038x + 0.1017) with a correlation coefficient of 0.928 using the standard curve and 
subsequently used to determine the protein concentrations of C2C12 cell lysates and collected 
conditioned media. To ensure accuracy, quintuplets (n=4) were performed per concentration.  
 
2.2.6 Dot blot optimization of primary antibodies 
Due to the sensitivity (at mid-femtomol of protein) of enhanced chemiluminescence 
(ECL) (Kricka, 1987), protein-protein interactions of lysate proteins with primary 
antibodies could result in ambiguous ‘false-positive’ signals. Thus, it is vital to 
optimize primary antibodies through simple dot blot analysis before proceeding to 
western blotting. Dot blot analysis provides an indication of a suitable dilution for 
western blotting and potentially prolongs the use of purchased antibodies (if higher 













Ovalbumin concentration (μg/ml) 
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optimized via dot blot analysis before proceeding to western blotting. Briefly, 1 μl of 
cell lysate was dotted onto a nitrocellulose sheet (Hybond-C™ Extra, Amersham), 
air-dried and blocked with 5% skim milk in TTBS (1 hour). Thereafter, nitrocellulose 
membrane was cut into single blocks and incubated in individual chambers with a 
range of chosen diluted primary antibodies, in TTBS (overnight at 4 °C). Starting from 
the dilution recommended by manufacturer, we increase the dilution series by 
two-fold (example shown in Fig. 2.2). Four dilution points were usually sufficient to 
see a variation in signal intensity. After primary incubation, the nitrocellulose 
membrane was washed and incubated in secondary HRP-linked antibodies (Table 2.3) 
in TTBS (1 hour) at room temperature. The antigen-antibody complex was visualized 
using an ECL kit (Immun-Star™ WesternC™ Chemiluminescent Kit, BioRad). The 
nitrocellulose membranes were exposed onto Biomax light film (Kodak), captured on 
VersaDoc™ MP imager (BioRad) and visualized with Quantity One software (BioRad). 
From the signal intensity of the ‘dot’, the primary antibody dilutions were chosen for 
western blotting. All dot blot optimized primary antibodies are shown in Table 2.3 
with the respective secondary antibodies. 
 





Fig. 2.2: Experimental design of the dot blot analysis for rabbit monoclonal anti-GAPDH antibody 
Dot blot analysis was utilized to optimize rabbit monoclonal anti-GAPDH antibody. 1 μl of cell protein 
lysates were ‘dotted’ onto nitrocellulose membrane (A) and incubated in the anti-GAPDH antibody 
dilutions in TTBS, starting with the manufacture’s recommended dilution 1:1000 (in bold) to 1:8000 . 
After blocking with 5% skim milk in TTBS and incubated with goat anti-rabbit secondary antibody 
(DAKO), the antigen-antibody complex was visualized with the addition of ECL reagent (Immun-Star™ 
WesternC™ Chemiluminescent Kit, BioRad) (B). From the signal intensity, the anti-GAPDH antibody 
dilution of 1:4000 (in bold) was chosen. 
        
 
1:1000  1:2000   1:4000  1:8000 
 
1:1000    1:2000   1:4000   1:8000 
‘Dotted’ protein lysate  
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2.2.7 Western blotting of C2C12 protein lysates and conditioned media 
Western blotting was performed according to Towbin et al. (1992) and used to 
determine protein expression levels during proliferation and differentiation of C2C12 
cells. 30 μg of total cell lysates or 50 μg of concentrated CM (protein concentration 
determined by Bradford assay, section 2.2.5) from each time point were resolved in a 
reducing 12.5% SDS-polyacrylamide gel at 18 mA/gel (Laemmli, 1970). Following 
electrophoresis in a Mini-PROTEAN®  3 cell apparatus (BioRad), the resolved proteins 
were transferred with an omniPAGE Electroblotting (Cleaver Scientific) at 400 V (4 
hours) onto nitrocellulose membrane (Hybond-C™ Extra, Amersham), stained with 
Ponceau S to verify equivalent loading, destained with TTBS and blocked with 5% 
skim milk in TTBS (1 hour). Thereafter, nitrocellulose membrane was incubated with 
primary antibodies against MyoD (554130, BD Biosciences), Myogenin (F5D, Santa 
Cruz), Wnt3a (YY-7, Santa Cruz), Wnt7 (H-40, Santa Cruz), Wnt10b (MAB2110 , R&D), 
and internal controls, α-tubulin (B-7, Santa Cruz) and GAPDH (14C10, Cell Signaling) 
in TTBS (see Table 2.3 for optimized primary antibody dilutions), overnight at 2 °C. 
Following primary antibody incubation, the nitrocellulose membrane was washed 
and incubated in secondary HRP-linked antibodies in TTBS (see Table 2.2 for 
secondary antibody dilutions) (1 hour), at room temperature. The antigen-antibody 
complex was visualized using an ECL kit (Immun-Star™ WesternC™ 
Chemiluminescent Kit, BioRad) according to manufacturer’s instructions. The 
nitrocellulose membranes were exposed onto Biomax light film (Kodak) and 
captured on VersaDoc™ MP imager (BioRad). The molecular weight of target 
antigens (Table 2.3) was determined from a standard curve (Fig. 2.3). Densitometry 





Fig. 2.3: Standard curve of log molecular weight pegGOLD protein marker-V standards relative to 
the relative mobility in a reducing 12.5% SDS-polyacrylamide gel 
The pegGOLD protein marker-V was used to determine the antigens of unknown molecular weight. 
Recombinant proteins of different size fragments are produced in E.coli with nine fragments sizes: 250, 
130, 95, 72, 55, 36, 28, 17 and 11 kDa. The linear regression formula was determined (y = -0.7358x + 
1.6464) with a correlation coefficient of 0.934 using the standard curve and subsequently used to 
determine the molecular weights of MHC, MyoD, Myogenin, MyoD, Wnt3a, Wnt7, Wnt10b, α-tubulin 
and GAPDH, in a 12.5% SDS-polyacrylamide gel. 
 
2.2.8 Immunocytochemistry 
Early and late passage C2C12 cells were plated onto coverslips in 24 well plates (80 
000 cells/well) and induced to differentiate when 80% confluence was reached. At 
the chosen time points (day 0 and 1), cells were fixed with 4% paraformaldehyde for 
10 minutes and non-specific sites were blocked with 5% donkey serum followed by 
incubation in optimized primary antibody (1:100 MyoD, BD Biosciences, 5.8A) in PBS, 
overnight at 2 °C. The fixed cells were washed and incubated in secondary antibody 
(1:4000 donkey anti-mouse FITC, Jackson) for 1 hour, washed and followed by 
incubation in nuclear stain, hoechst (Sigma) for 5 minutes. Lastly, the fixed cells were 
washed and coverslips were mounted onto microscope slides with movial and 
viewed under Carl Zeiss LSM 710 NLO confoCor 3 confocal microscopy (Carl Zeiss, 
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Zen software (Carl Zeiss), 2008. 
 
2.2.9 Statistical analysis 
For statistical purpose, each experiment were performed a minimum of 3to 9 
replicates (n=3 for MyoD, Myogenin, Wnt3a, 7 and 10b expression analysis; n=5 for 
analysis of proliferation; n=6 for SA-β-gal assay and α-tubulin expression analysis; 
n=9 for GAPDH expression analysis). All data are represented as mean ±standard 
error of the means (SEM) for each data set shown. The paired Student’s t-test was 
performed for parametric data and paired Mann-Whitney U test for non-parametric 
data. All statistical tests were performed using the Genstat 12th edition statistical 




2.3.1 Late passage C2C12 cells show an increase in senescence-associated 
β-galactosidase staining 
Somatic cells enter a state of irreversible growth arrest after several cycles of division, 
a process termed replicative senescence (Dimri et al., 1995). Therefore, to determine 
the levels of replicative senescence, we analyzed senescence-associated 
β-galactosidase (SA-β-gal) expression in passage 13 (i.e. early passage) and passage 
33 (i.e. late passage) C2C12 cells. Visibly, we observed more X-gal stain in the late 
passage than the early passage cells (Fig. 2.4A). Indeed, this was confirmed by the 
quantification of the X-gal stained images: passage 13 had 75% senescent cells total 
number of cells in field of view compared to 91% at passage 33, positive for SA-β-gal 
stain (Fig. 2.4B). This suggests that late passage cells have significantly higher 
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Fig. 2.4: Replicative senescence of passage 13 and passage 33 C2C12 cells 
Passage 13 and 33 C2C12 cells were assessed for senescence-associated β-galactosidase (SA-β-gal) 
activity by staining with X-gal substrate. Cells were plated into growth medium and upon reaching 
40% confluency, growth medium was replaced with fresh X-gal staining solution for 16 hours. 
Brightfield images (A, 10X objective) of SA-β-gal staining indicated that late passage (passage 33) show 
an increase in percentage senescence compared to early passage (passage 15) cells with a difference 
of 16% (B). Percentage senescence was determined as number of stained cells divided by the total 
number of cells per field of view. Experiment repeated, n=6, for each passage. (*p < 0.01). 
 
2.3.2 Late passage C2C12 cells showed increase rate of proliferation 
Proliferation capacity of early and late passage C2C12 cells was assessed. Results 
indicated that late passage cells were able to significantly achieve confluence (~2.5 
million cells) by day 2, whereas, early passage cells were incapable (Fig. 2.5A). The 
population fold increase was also assessed and revealed population doubling 
(two-fold increase in population) at 1.7 days (~40.8 hours) for early passage cells, and 
an earlier doubling at 1.2 days (~28.8 hours) for late passage cells (Fig. 2.6B). Thus 
late passage cells showed a faster rate of proliferation than early passage cells.  
 
Early passage (passage 13) 
Late passage (passage 33) 
* 
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Fig. 2.5: Proliferation of early and late passage C2C12 cells 
Early and late passage C2C12 cells were plated into T75 flasks containing growth medium, trypsinized 
and counted at day 0, 1, and 2 with a hemocytometer. The results showed similar proliferative rates 
from day 0 to 1 of the two passages, however, the rate of the old passage cells increased significantly 
from day 1 to 2 (A). The population of early passage cells doubled at 1.7 days (B, arrow) whereas the 
late passage cells doubled earlier at 1.2 days (B). Experiment repeated, n=5, for each passage. (*p < 
0.01). 
 
2.3.3 Late passage C2C12 cells continued to proliferate even under differentiation 
inducing medium 
The process of myogenic differentiation includes the fusion of individual myoblasts to 
form multinucleated myotubes. Therefore, we monitored this process by the 
morphological appearance of multinucleated myotubes under differentiation 
conditions. Early and late passage C2C12 cells were induced to differentiate and 
brightfield images were captured at day 0, 1, 5 and 7. Early passage cells readily gave 
rise to multinucleated myotubes and myotubes were visible as early as day 5 (Fig. 
2.6A). However, late passage cells lacked significant myotube formation throughout 
differentiation, even at day 7 (Fig. 2.6B). This suggests that late passage cells do not 
differentiate under standard conditions and possibly continue to proliferate. In 
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Fig. 2.6: Morphological assessment of differentiation in early and late passage C2C12 cells 
Differentiation of early and late passage C2C12 cells was compared visually by the formation of 
multinucleated myotubes. Early and late passage cells were plated into 6 well plates containing 
growth medium and upon reaching 80% confluency were induced to differentiate by replacing growth 
medium with differentiation medium. Brightfield images were captured at days 0, 1, 5 and 7. 
Brightfield images (magnification 10×) showed that early passage cells (A) readily form multinucleated 
myotubes (arrow heads), whereas late passage cells (B) displayed no visible myotube formation.  
 
2.3.4 Expression levels of α-tubulin and GAPDH do not change during 
differentiation within early and late passage C2C12 cells 
To accurately determine the changes in protein expression, equal loading of cell 
lysate proteins are essential. Therefore, it is common practice to probe for proteins 
that are expressed constitutively, regardless of the cellular or culture conditions to 
correct for protein loading. House-keeping genes such as α-tubulin, β-tubulin, 
GAPDH and β-actin are often used as loading controls. However, the protein 
expression of these house-keeping genes have been shown to change under certain 
conditions such as fluctuations in cell confluency even under equivalent loads of 
day 0 (Control) day 1 day 5 day 7 
day 0 (Control) day 1 day 5 day 7 
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protein (Greer et al., 2010). For our expression analysis, we intended to use either 
α-tubulin or GAPDH as internal control proteins but firstly we proceeded to 
determine whether differentiation affected the expression of the two proteins within 
early and late passage C2C12 cells. We found no significant change in their 
expression during differentiation within early and late passage cells (Fig. 2.7 and 2.8). 
As a result, these internal controls were used to ensure equal protein loading during 
western blotting. In all subsequent experiments, loading was checked using either 
α-tubulin or GAPDH. Data was then presented as i) raw data and ii) change in 
expression relative to day 0 (control). In the latter, the expression levels observed in 
proliferating cells (day 0, control) were subtracted from the levels observed during 



































Fig. 2.7: α-tubulin expression levels of differentiating C2C12 cells 
The densitometry values of α-tubulin were compared during differentiation in early and late passage 
C2C12 cells. Early and late passage cells were plated into flasks containing growth medium and upon 
reaching 80% confluency were induced to differentiate by replacing growth medium with 
differentiation medium. Cells were harvested at days 0, 1, 3, 5, and 7 of differentiation. The harvested 
cell lysates were probed for α-tubulin via western blotting, ponceau stained to verify equivalent 
loading (B and C) and densitometry values determined (A). The values indicated that α-tubulin 
expression levels did not change significantly during differentiation within early and late passage cells. 
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Fig. 2.8: GAPDH expression levels of differentiating C2C12 cells 
The densitometry values of GAPDH were compared during differentiation in early and late passage 
C2C12 cells. Early and late passage cells were plated into flasks containing growth medium and upon 
reaching 80% confluency were induced to differentiate by replacing growth medium with 
differentiation medium. Cells were harvested at days 0, 1, 3, 5, and 7 of differentiation. The harvested 
cell lysates were probed for GAPDH via western blotting, ponceau stained to verify equivalent loading 
(B and C) and densitometry values determined (A). The values indicated that GAPDH expression levels 
did not change significantly during differentiation within early and late passage cells. Experiment 
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2.3.5 Total MyoD but not Myogenin levels are elevated in late passage C2C12 cells 
MyoD, Myogenin, Myf5 and Mrf4 are transcription factors, collectively known as the 
MRFs, play a central role in regulating myogenic activation and differentiation 
(Holterman and Rudnicki, 2005). In our studies, we chose two of the four MRFs as 
molecular markers: MyoD, a marker for activation and myogenic differentiation 
commitment and Myogenin, a marker for terminal differentiation (Holterman and 
Rudnicki, 2005), to assess differentiation in early and late passage C2C12 cells at the 
molecular level. Unexpectedly, analysis of total MyoD protein levels as well as the 
change in MyoD levels in response to differentiation, revealed significantly lower 
expression in early passage cells (Fig. 2.9A and B). The low MyoD expression level 
suggests that the differentiation capacity is reduced in early passage cells. However, 
this is not consistent with the brightfield images of differentiating early passage cells 
(Fig. 2.6A), which readily differentiate to form multinucleated myotubes. Conversely, 
the elevated expression in the late passage cells suggests an attempt by the cells to 
compensate (for the reduced differentiation) via up-regulation of MyoD. Expression 
levels of Myogenin indicated consistently higher levels in early passage cells during 
differentiation (Fig. 2.10). Late passage cells showed relatively constant expression 
levels during differentiation (Fig. 2.10A). However, change in Myogenin expression 
levels relative to day 0 revealed an increased level at day 1 and a subsequent slower 
decline in myogenesis in early vs. late passage cells (Fig. 2.10B.). Furthermore, it is 
clear that Myogenin up-regulation at day 3 is significantly lower in late passage 
compared to early passage cells (Fig. 2.10B). The low levels of Myogenin seen in late 
passage cells suggest a lack of commitment to terminal differentiation in late passage 
cells. The Myogenin analysis agrees with the brightfield images of differentiating 




























Fig. 2.9: MyoD expression profile of differentiating C2C12 cells 
The expression of MyoD from western blotting was compared during differentiation in early and late 
passage C2C12 cells. Early and late passage cells were plated into flasks containing growth medium 
and upon reaching 80% confluency were induced to differentiate by replacing growth medium with 
differentiation medium. Cells were harvested at days 0, 1, 3, 5 and 7 of differentiation. The harvested 
cell lysates were probed for MyoD and α-tubulin via western blotting (C and D) and densitometry 
values (A and B) were determined for early and late passage cells. Densitometry data (A and B) 
indicated that MyoD expression levels were higher in the late passage than the early passage cells. 
Experiment repeated, n=3, for each passage. (*p < 0.05, **p < 0.005: early vs. late passage MyoD 
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Fig. 2.10: Myogenin expression profile of differentiating C2C12 cells 
The expression of Myogenin from western blotting was compared during differentiation in early and 
late passage C2C12 cells. Early and late passage cells were plated into flasks containing growth 
medium and upon reaching 80% confluency were induced to differentiate by replacing growth 
medium with differentiation medium. Cells were harvested at days 0, 1, 3, 5 and 7 of differentiation. 
The harvested cell lysates were probed for Myogenin and α-tubulin via western blotting (C and D) and 
densitometry values (A and B) were determined for early and late passage cells. Densitometry data (A 
and B) indicated that Myogenin expression levels were higher in the early passage than the late 
passage cells. Experiment repeated, n=3, for each passage. (**p < 0.005: early vs. late passage 
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2.3.6 Localization of MyoD does not differ during differentiation of early and late 
passage C2C12 cells 
The total MyoD levels were surprisingly higher in the late passage C2C12 cells; 
therefore we further determined whether translocation of MyoD to the nucleus was 
decreased in late passage cells. Confocal analysis of cellular localization revealed 
more MyoD in the nucleus of C2C12 cells at day 1 of differentiation compared to day 
0 within both early and late passage cells, respectively (Fig. 2.11B and D). 
Furthermore, visually, there was no apparent difference in the levels of nuclear 









































Fig. 2.11: Cellular localization of MyoD in differentiating C2C12 cells 
Cellular localization of MyoD was determined in early and late passage C2C12 cells during differentiation. Early and late passage cells were plated into wells with coverslips in growth medium 
and induced to differentiate by replacing growth medium with differentiation medium. Cells were fixed at day 0 and day 1, and stained for MyoD (FITC, green) and nucleus (hoechst, blue). 
Arrow heads indicate nuclear localization of MyoD at day 1 for early and late passage cells, respectively.
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2.3.7 Analysis of cytosolic and secreted Wnt levels in proliferating and 
differentiating C2C12 cells 
Wnts regulate differentiation through the temporal switch from Notch to Wnt 
signaling (Conboy et al., 2003). However, in aging muscle, certain Wnt proteins have 
been shown to specifically regulate myogenesis of satellite cells (Brack et al., 2007; 
Vertino et al., 2005). Therefore, we aim to determine the cytosolic levels of Wnt3a, 7 
and 10b during differentiation of early vs. late passage C2C12 cells. Given that Wnts 
are secreted proteins, we further analyzed the secreted levels of the three Wnt 
isoforms in the CM of differentiating early vs. late passage cells. 
 
2.3.7.1 Cytosolic Wnt3a expression is elevated with reduced secretion in late 
passage C2C12 cells 
The absolute expression of cytosolic Wnt3a was found to be consistently higher in 
the late passage C2C12 cells during differentiation (Fig. 2.12). This supports the 
premise that high Wnt3a levels lead to a fibrotic lineage conversion with reduced 
myogenesis in late passage cells (Brack et al., 2007). Indeed, myogenic capability is 
reduced in late passage cells confirmed by the lack of myotube formation in the 
brightfield images of differentiating early and late passage cells (Fig. 2.6) and lower 
levels of Myogenin expression (Fig. 2.10). Contradictory to the cytosolic levels and 
expression trends, the secreted levels were marginally higher in the early passage 
cells (Fig. 2.13A). Therefore, the cytosolic Wnt3a levels and trends do not reflect the 
secreted Wnt3a levels seen in both early and late passage cells. Lastly, analysis of 
Wnt3a in CM from proliferating cells (day 0-CM) failed to detect Wnt3a but was 
detected in CM from differentiating cells (day 1- to day 5-CM) (Fig. 2.13B). This 
agrees with the hypothesis that Wnt signaling by Wnt3a protein plays a role in 






























Fig. 2.12: Wnt3a expression profile of differentiating C2C12 cells 
The expression of Wnt3a from western blotting was compared during differentiation in early and late 
passage C2C12 cells. Early and late passage cells were plated into flasks containing growth medium 
and upon reaching 80% confluency were induced to differentiate by replacing growth medium with 
differentiation medium. Cells were harvested at days 0, 1, 3, 5 and 7 of differentiation. The harvested 
cell lysates were probed for Wnt3a and GAPDH via western blotting (C and D) and densitometry values 
(A and B) were determined for early and late passage cells. Densitometry data (A and B) indicated that 
Wnt3a expression levels were higher in the late passage than the early passage cells along with a 
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Fig. 2.13: Secreted Wnt3a levels of differentiating C2C12 cells 
The levels of secreted Wnt3a were compared during differentiation of early and late passage C2C12 
cells. Early and late passage cells were plated into flasks containing growth medium and upon reaching 
80% confluency were induced to differentiate by replacing growth medium with differentiation 
medium. Conditioned media was collected at days 0, 1, 3 and 5 of differentiation, concentrated using 
PEG 20 000, probed for Wnt3a via western blotting (B) and densitometry values determined (A). The 
densitometry values (A) generally showed higher Wnt3a secreted levels in the early passage cells. 
Ponceau stained blots (B) to indicate equivalent loading of conditioned media. Secretion of Wnt3a 
from each time point were subtracted from the Wnt3a levels present in differentiation media (DM) in 
order to accurately reflect the increase in secretion by the early and late passage cells. Experiment 
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2.3.7.2 Cytosolic and secreted Wnt7 levels rapidly declined in differentiating late 
passage C2C12 cells 
Wnt7 isoform has been suggested to play a role in lineage specification and 
differentiation (Polesskaya et al., 2003). However, levels of Wnt7 in myoblasts from 
aging muscle have largely been unknown. Hence, we aim to define the role and 
expression levels of Wnt7 during differentiation in ‘aging’ C2C12 myoblast. The 
cytosolic levels of Wnt7 were lower during initial differentiation in early passage cells. 
Expression in early passage cells peaked at day 3 whereas late passage cells reached 
a maximum expression at day 1 followed by a rapid decline in levels during 
differentiation (Fig. 2.14A and B). Similarly, the secreted levels with early passage 
cells were elevated at a slower rate than late passage cells, the latter showing a 
rapidly decreased secretion throughout differentiation (Fig. 2.15A). This rapid 
decline in Wnt7 cytosolic and secreted levels suggest reduced differentiation in late 
passage cells. This agrees with the premise that signaling via Wnt7 proteins 
promotes myogenic specification and progression (Polesskaya et al., 2003). Lastly, 
we failed to detect Wnt7 in CM from proliferating cells but were detected in CM 
from differentiating cells (Fig. 2.15B) further supporting a role for Wnt7 protein in 








































Fig. 2.14: Wnt7 expression profile of differentiating C2C12 cells 
The expression of Wnt7 from western blotting was compared during differentiation in early and late 
C2C12 passage cells. Early and late passage cells were plated into flasks containing growth medium 
and upon reaching 80% confluency were induced to differentiate by replacing growth medium with 
differentiation medium. Cells were harvested at days 0, 1, 3, 5 and 7 of differentiation. The harvested 
cell lysates were probed for Wnt7 and GAPDH via western blotting (C and D) and densitometry values 
(A and B) were determined for early and late passage cells. Densitometry data (A and B) indicated an 
increasing trend of Wnt7 expression in early passage cells and conversely, a decreasing trend in late 
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Fig. 2.15: Secreted Wnt7 levels of differentiating C2C12 cells 
The levels of secreted Wnt7 were compared during differentiation of early and late passage cells. Early 
and late passage cells were plated into flasks containing growth medium and upon reaching 80% 
confluency were induced to differentiate by replacing growth medium with differentiation medium. 
Conditioned media was collected at days 0, 1, 3 and 5 of differentiation, concentrated using PEG 20 
000, probed for Wnt7 via western blotting (B) and densitometry values determined (A). Densitometry 
data (A and B) indicated an increasing trend of Wnt7 secreted levels in early passage cells and 
conversely, a decreasing trend in late passage cells during differentiation. Ponceau stained blots (B) to 
indicate equivalent loading of conditioned media. Secretion of Wnt7 from each time point were 
subtracted from the Wnt7 levels present in differentiation media (DM) in order to accurately reflect 
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2.3.7.3. Cytosolic and secreted Wnt10b levels are lower in late passage C2C12 cells 
Wnt10b has been implicated in regulating adipogenic conversion of myoblasts in 
aging muscle (Vertino et al., 2005). Therefore, we set out to analyze the expression 
levels of Wnt10b during differentiation of ‘aging’ C2C12 myoblasts. Early passage 
cells displayed consistently higher cytosolic Wnt10b levels (Fig. 2.16A and B). The 
late passage cells had lower levels of expression of cytosolic Wnt10b which seem to 
suggest a loss in myogenic capability. Indeed, late passage cells through Myogenin 
expression analysis (Fig. 2.10) and brightfield images of differentiating late passage 
cells (Fig. 2.6) revealed impaired differentiation. This loss of myogenic capability with 
lower Wnt10b cytosolic levels revealed in late passage cells could likely be associated 
with lineage conversion, from myogenic to adipogenic or fibrogenic lineage (Brack et 
al., 2007; Vertino et al., 2005). The secreted levels, similar to Wnt3a secreted levels, 
do not resemble the cytosolic Wnt10b levels in both passage cells. Unlike the 
cytosolic levels, the secreted Wnt10b in the late passage cells was higher at day 1 
and thereafter, the secreted levels were similar (Fig. 2.17A). Lastly, similar to the 
secretion analysis of Wnt3a and 7, we failed to detect Wnt10b in CM from 
proliferating cells but were detected in CM from differentiating cells (Fig. 2.17B). 
Therefore, Wnt10b not only play a role in regulating a switch from myogenic to 
adipogenic lineage but also likely to play a role in differentiation which to date has 
not been shown. The three isoforms Wnt3a, 7 and 10b have their distinct roles but 





































Fig. 2.16: Wnt10b expression profile of differentiating C2C12 cells 
The expression of Wnt10b from western blotting was compared during differentiation in early and late 
C2C12 passage cells. Early and late passage cells were plated into flasks containing growth medium 
and upon reaching 80% confluency were induced to differentiate by replacing growth medium with 
differentiation medium. Cells were harvested at days 0, 1, 3, 5 and 7 of differentiation. The harvested 
cell lysates were probed for Wnt10b and GAPDH via western blotting (C and D) and densitometry 
values (A and B) were determined for early and late passage cells. Densitometry data (A and B) 
indicated that Wnt10b expression levels were higher in the early passage than the late passage cells. 
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Fig. 2.17: Secreted Wnt10b levels of differentiating C2C12 cells 
The levels of secreted Wnt10b were compared during differentiation of early and late passage C2C12 
cells. Early and late passage cells were plated into flasks containing growth medium and upon reaching 
80% confluency were induced to differentiate by replacing growth medium with differentiation 
medium. Conditioned media was collected at days 0, 1, 3 and 5 of differentiation, concentrated using 
PEG 20 000, probed for Wnt3a via western blotting (B) and densitometry values determined (A). 
Densitometry data (A) indicated that early passage has a high level of Wnt10b secreted level during 
terminal differentiation and late passage, a higher Wnt10 secreted level during initial stages of 
differentiation. Ponceau stained blots (B) to indicate equal protein loading of conditioned media. 
Secretion of Wnt10b from each time point were subtracted from the Wnt10b levels present in 
differentiation media (DM) in order to accurately reflect the increase in secretion by the early and late 
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Aging of skeletal muscle ultimately results in extrinsic changes that directly impact 
satellite cell activity and capacity. These changes have been highlighted and 
collectively result in poor regeneration and repair compared to that of young muscles. 
Parabiotic pairing between young and old mice suggest that the exposure of satellite 
cells to circulatory serum factors of young mice can rejuvenate the satellite cells in 
muscles of old mice and show effective repair (Conboy et al., 2005). Further studies 
suggest that these systemic factors in the serum could be Wnt and TGF-β protein 
factors. Wnt protein isoforms have been shown to act as both activators and 
inhibitors of myogenic differentiation (Brack et al., 2008; Florini et al., 1986). In our 
studies, we utilized the C2C12 myoblast cell line (Yaffe and Saxel, 1977), to establish 
the expression profiles of three Wnt isoforms, Wnt3a, 7 and 10b, in their cytosolic 
and secreted forms during differentiation. Furthermore, the expression profile of two 
MRFs, MyoD and Myogenin, were also determined to compare, on a molecular level, 
the state of differentiation in early vs. late passage C2C12 cells. 
 
To ‘age’ the C2C12 cells (initial passage 13), we allowed many cycles of cell division 
with prolonged sub-culturing until passage 33 and performed senescence-associated 
β-galactosidase (SA-β-gal) staining. β-galactosidase, when detected at pH 6, is 
relatively specific for SA-β-gal and not acid-lysosomal β-galactosidase (active at pH 4) 
(Kurz et al., 2000). Experimentally, an increase in passage numbers should 
correspond to an increase in senescence due to the greater number of cell cycle 
divisions. Our SA-β-gal staining results did show an increase in percentage 
senescence in late passage cells. However, it should be noted that C2C12 cells are 
considered as an ‘immortal’ cell line with a corrupt cell cycle (Cornelison, 2008). This 
could explain why both the early and late passage cells have high SA-β-gal staining. It 
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is also possible that acid lysosomal β-galactosidase was detected in a non-specific 
manner due to prolonged incubation (post 16 hours). These results should therefore 
be observed with caution.  
 
We also identified interesting characteristics of late passage C2C12 cells. Firstly, the 
tendency of late passage cells to undergo differentiation is impaired when exposed 
to differentiation cues. Instead of differentiating, late passage cells continued to 
proliferate under differentiation media although this has to be verified with 
proliferation markers such as Ki-67. Secondly, contrary to our senescence results, the 
proliferative rate of late passage cells was higher than early passage cells, suggesting 
that late passage cells undergo division at a faster rate than early passage cells. 
Proliferation studies using BrdU incorporation by Brack et al. (2007) have shown that 
satellite cells from aging muscle of mice proliferate poorly which contradicts our 
results. It should be noted that in their studies, primary culture was used and not a 
myoblast cell line hence the contradictory results. Therefore, it seems that by 
maintaining C2C12 cells in growth medium for extended period results in a 
proliferative phenotypic change whereby cells acquire an enhanced proliferative 
capability and in the process lose their differentiation potential, as seen in our late 
passage cells. Contrary to our differentiation study, Conboy et al. (2003) has 
demonstrated that prolonged maintenance of satellite cells from old muscles which 
are known to have a defective myogenic differentiation, differentiated as effectively 
as satellite cells from young muscle. However, it should be noted that in their studies, 
primary culture was used rather than a cell line. Nonetheless, they have also shown 
that prolonged maintenance in culture can alter the phenotype of the cells of 
interest. Collectively, this shows that the surrounding media could possibly change 






Fig. 2.18: Balance of proliferation and differentiation of early and late C2C12 passage cells 
Late passage C2C12 cells through extensive sub-culturing in growth medium lose their ability to 
differentiate even in the presence of differentiation cues, and rather adopt a proliferative phenotype. 
On the other hand, early passage C2C12 cells respond effectively to differentiation cues and 
differentiate into myotubes but do not proliferate as rapidly as late passage cells.  
 
MyoD and Myogenin are transcription factors that regulate myogenic differentiation 
(Charge and Rudnicki, 2004). The expression levels of both transcription factors give 
an indication of the state of myogenic determination and differentiation at the 
molecular level in early and late passage C2C12 cells. As expected, Myogenin levels 
increased from day 0 to day 1 in early passage but not in late passage cells during 
differentiation. This agrees with the lack of fusion and myotube formation observed 
morphologically in the brightfield images of late passage cells.  
 
Unexpectedly, our results indicated higher total MyoD levels in late compared to 
early passage differentiating cells. These results could be interpreted as a 
compensation effect in the late passage C2C12 cells due to the fact that 
differentiation capacity is reduced, the cells up-regulate MyoD in an effort to commit 
more cells to myogenic differentiation. Previous studies by Schabort et al. (2009) 
emphasized the importance of MyoD stability during differentiation. In their work, 
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they demonstrated that TGF-β treated C2C12 myoblasts have reduced 
differentiation capacity and this correlated with the elevated degradation of MyoD. 
It is possible that a similar mechanism in the late passage cells could be occurring. 
Our late passage cells could have a higher rate of degradation of MyoD compared to 
early passage cells. Given that MyoD is required for the up-regulation of Myogenin 
(Fuchtbauer and Westphal, 1992), if MyoD is rapidly degraded before it is able to 
bind the Myogenin promoter, transcription and translation of Myogenin would be 
compromised which would negatively impact myogenic differentiation. This could be 
tested by analyzing the half-life of MyoD with the use of cyclohexamide. Because 
MyoD is a transcription factor, we further determine the presence of nuclear MyoD 
and visually distinguish the difference in nuclear MyoD between early and late 
passage cells. Confocal analysis of cellular localization did not reveal a difference in 
the translocation of MyoD to the nucleus of late vs. early passage cells at day 1 of 
differentiation, suggesting no difference in the level of potentially active nuclear 
MyoD, however quantification of the levels of nuclear MyoD would be more reliable. 
The method by Vindelov et al. (1983) to extract nuclei from various cell lines for flow 
cytometric DNA analysis could be adopted to extract nuclei of differentiating early 
and late passage C2C12 cells. These extracted intact nuclei could further be ruptured, 
probed for nuclear MyoD via western blotting and quantified through densitometry. 
This method eliminates contaminating cytosolic MyoD and thus only levels of nuclear 
MyoD is compared between differentiating early vs. late passage cells. The 
quantification of nuclear MyoD would indicate differentiation state of early and late 
passage cells.  
 
Besides translocation, total levels and protein stability, protein modifications can 
affect protein activity. Gillespie et al. (2009) have shown that MyoD modification via 
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direct phosphorylation by p38γ results in tighter binding to the Myogenin 
promoter – this tight binding represses the expression of Myogenin. MyoD in this 
conformation recruit H3K9 histones which are continuously methylated by KMT1A 
methyltransferase which also contribute to repression of Myogenin expression. In 
the absence p38γ activity, MyoD would bind to the Myogenin promoter and in this 
conformation would not recruite KMT1A methyltransferase. With the absence of 
KMT1A methyltransferase, Myogenin is transcribed and expressed, resulting in 
effective differentiation. In this respect, it would be interesting to compare the 
expression of total and active p38γ in early vs. late passage C2C12 cells. Taken 
together, our data suggests that protein modifications, stability and localization are 
just as important as total protein levels in controlling myogenic differentiation.  
 
Wnt signaling via Wnt proteins are known to play a role in regulating myogenic 
differentiation, specification and lineage progression by suppressing Notch pathway 
(Brack et al., 2008; Polesskaya et al., 2003). Key findings in our results support this 
hypothesis. Firstly, we failed to detect any secreted Wnts in conditioned media from 
proliferating cells in both early and late passage cells. However, all three Wnt 
isoforms were detected in CM from differentiating cells in both passages. This 
suggests that our investigated Wnts do not a play role in proliferation but myogenic 
differentiation and lineage progression. Secondly, cytosolic Wnt3a, 7 and 10b 
expression increased in response to differentiation cues in early passage C2C12 cells. 
However, only Wnt3a cytosolic expression levels increased in late passage cells. 
Furthermore, secreted Wnt7 levels decreased in response to differentiation in late 
passage, but not early passage cells. The increase levels of Wnt proteins during 
differentiation suggest a possible role of Wnt isoforms in differentiation of early 
passage cells. Polesskaya et al. (2003) and Brack et al. (2008) reported that Wnt7a 
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and 7b, and 3a mRNA transcript level increases in regenerating muscle, respectively. 
The increase in Wnt7a and 7b, and 3a mRNA transcripts would likely be followed by 
an increase in Wnt3a, 7a and 7b protein levels. These mRNA transcripts are likely to 
be translated into their respective proteins, undergo post-modification (glycosylation 
and palmitoylation) and secreted to the external environment. The decrease in 
myogenesis could be explained by the decreased cytosolic and secreted Wnt7 levels 
as observed in late passage cells. And lastly, Wnt3a, 7 and 10b isoforms were 
detected in the differentiation media and not growth media, most likely in the 1% 
horse serum used to induce differentiation of C2C12 cells. The presence of these 
Wnts in differentiation media alone suggest their roles in the myogenic 
determination and differentiation induced by exposure to 1% horse serum.  
 
High levels of Wnt3a are known to impede myogenesis (Brack et al., 2007). Brack et 
al. (2007) demonstrated that injection of endogenous Wnt3a into young regenerating 
muscle during the initial stages of regeneration resulted in an increase in connective 
tissue and poor regeneration. Our results showed higher levels of cytosolic but not 
secreted Wnt3a in late compared to early passage cells. Therefore, the increase 
cytosolic Wnt3a seen in late passage cells could explain the decrease myogenesis. 
However, the low level of secreted Wnt3a by late passage cells is puzzling. This seems 
to suggest that the cytosolic Wnt3a proteins are stored and not secreted into the 
media.  
 
Wnt10b has been implicated in directing satellite cells into an adipogenic lineage. 
Akimoto et al. (2005) demonstrated that cyclic mechanical stretching prevents 
adipogenesis in C2C12 myoblasts when cultured in adipogenic induction medium. 
This inhibition is associated with the up-regulation of Wnt10b mRNA transcript. 
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However, knock-out studies by Vertino et al. (2005) of Wnt10b (Wnt10b-/-) in mice 
revealed no difference in myogenic capacity in relation to the wild-type mice. 
Subsequently, from mRNA analysis, it was discovered that Wnt10b-/- myoblasts 
over-expressed Wnt7b to compensate for the lack of Wnt 10b expression, leading to 
successful myogenesis (Vertino et al., 2005). Further analysis of mRNA transcript 
levels revealed the absence of this compensation by Wnt7b in aging Wnt10b-/- 
myoblasts, lead to an adipogenic lineage conversion (Vertino et al., 2005).  
 
This compensation effect is not seen in early passage cells with elevated levels of 
both Wnt7 and 10b. However, late passage cells initially display this effect with 
elevated Wnt7 levels from day 0 to 1 but this compensation is lost with progressive 
decline in Wnt7 levels post-day 1, concurrently with lower levels of Wnt10b during 
differentiation. The combined decrease in cytosolic and secreted levels of Wnt7 and 
Wnt10b in late passage cells supports the eventual loss of myogenic capability. It 
would be interesting to analyze the adipogenesis of the late passage cells with 
Oil-red O stain to visualize the degree of lipid accumulation. 
 
Secretion of Wnt proteins is essential to exert their effect on neighboring cells, 
therefore analyzing secretion levels is crucial. We determined the ratio of secretion 
to cytosolic levels of Wnt3a, 7 and 10b in both early and late passage C2C12 cells 
(Table 2.4). The ratio indicated substantially higher secretions of Wnt7 and 10b, in 
the early compared to the late passage cells. This indicates that although cytosolic 
Wnt7 and 10b were low, high levels of both proteins are immediately secreted by 





Table 2.4: Summary of secreted relative to cytosolic levels of the three key Wnt isoforms 
Isoforms Passage  day 1 day 3 day 5 
C S* S/C C S* S/C C S* S/ C 
Wnt3a  Early 6175  12938  2.1  8946  2026  0.2  11747  21339  1.8  
Late 11214  9081  0.8  14446  1539  0.1  9145  546  0.1  
Wnt7 Early  3569  39753  11.1  8175  56319  6.9  2938  11082  3.8  
Late  10456  59284  5.7  -1009  21989  -21.8  -6242  15231  -2.4  
Wnt10b Early  8090  3160  0.4  4214  1637  0.4  9341  15461  1.7  
Late -5447  22716  -4.2  -2398  2220  -0.9  -1919  13822  -7.2  
cytosolic ;*secreted  
The ratio of secreted to cytosolic levels was assessed in early and late passage C2C12 cells. Results of 
the ratio values indicate high Wnt7 and 10b ratios (highlighted in bold) which suggest higher secreted 
levels to cytosolic in early cells compared to late passage cells. This high ratio of secretion to cytosolic 
levels indicate the role of both Wnt7 and 10b in promoting myogenesis and alternatively, lower ratio, 
a decrease in myogenesis. 
 
In summary, our studies have for the first time analyzed the profile of cytosolic and 
secreted Wnt3a, 7 and 10b in early and late passage proliferating and differentiating 
C2C12 cells. Our results revealed key characteristics of early and late passage cells: 
early passage cells differentiate effectively whereas late passage cells differentiate 
poorly. Our results also support the premise that elevated Wnt3a decreases 
myogenesis, whereas elevated Wnt7 and 10b promotes. Furthermore, Yaffe and 
Saxel (1977) enhanced the differentiation in their isolated C2 myoblast cell lines by 
substituting growth medium (containing 20 % fetal calf serum) with differentiation 
medium (containing 10% horse serum). The factors that enhanced the differentiation 
have largely been unknown. However, we speculate the presence of Wnt3a, 7 and 
10b in differentiation medium could be the crucial factors for the observed enhanced 
differentiation. However, our analysis of myogenic differentiation have been done 
with a myoblast cell line which are known have a corrupt cell cycle through the 
accumulation of mutations. Therefore, it is crucial to repeat the experiments using 
primary culture myoblasts. Lastly, from our results, we speculate the possible use of 
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Wnt7 and 10b to promote myogenesis in muscles deficient in myogenesis such as 
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ABSTRACT 
Satellite cells are muscle stem cells that play a role in regeneration and repair of 
injured skeletal muscle. This process of myogenesis by satellite cells declines with age. 
In support of this hypothesis, our previous analysis of differentiating C2C12 
myoblasts revealed that late passage cells lacked differentiation capacity 
characterized by reduced Myogenin and low Wnt7 expressions. Parabiotic studies 
have shown that satellite cells with reduced myogenesis can be rejuvenated to 
undergo effective myogenesis when exposed to young environment. In the current 
study, we used the media conditioned from early passage cells (conditioned media) 
which we previously determined to have high levels of differentiation promoting 
Wnt3a and 7 proteins, and determined whether this media could alter the myogenic 
capacity of late passage C2C12 cells. 
 
The results from the cross-over experiment indicated that Myogenin and MHC levels 
were elevated in differentiating late passage cells in response to ‘young’ media, 
whereas early passage cells treated with ‘old’ media, surprisingly showed a slight 
increase in both proteins. Cytosolic Wnt3a and 7 in late passage cells treated with 
‘young media’ were increased compared to control. Early passage cells treated with 
‘old’ media showed significantly decreased levels of Wnt3a and 7. In summary, both 
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early and late passage cells showed increased MHC expression in response to their 




Satellite cells are quiescent muscle stem cells located between the sarcolemma and 
basal lamina along myofibers, and play a role in regeneration and repair of injured 
skeletal muscle (Charge and Rudnicki, 2004; Mauro, 1961). They are characterized by 
their anatomical location, molecular marker expression and function (Brack and 
Rando, 2007). Following an injury, satellite cells are activated from their quiescent 
state, begin to proliferate (now called myoblasts) and after several cycles of 
proliferation, eventually differentiate and fuse with each other (or existing myofibers), 
to form new myotubes to complete the repair process. The up-regulation of several 
transcription factors plays a pivotal role in this process. These include the expression 
of myogenic regulatory factor (MRF) expression such as MyoD, Myf5, Myogenin and 
Mrf4 (Fuchtbauer and Westphal, 1992; Gayraud-Morel et al., 2007). The repair 
process is accompanied by satellite cell self-renewal, which ensures that, after 
repeated rounds of regeneration, the satellite cell population is maintained. 
 
Sarcopenic muscles are aging muscles typified by an increase in resident adipoctyes, 
fibroblasts and muscle atrophy which results in reduced muscle mass (Gopinath and 
Rando, 2008; Solomon and Bouloux, 2006). Contrary to young muscle, sarcopenic 
muscle is hampered by poor regeneration and repair; thus in the presence of a 
severe injury, fibrosis at the site of injury is prevalent (Brack et al., 2007). This 
reduced capacity for myogenesis is at least in part due to the altered extrinsic 
environment (Brack and Rando, 2007). Aging skeletal muscle is characterized by a 
80 
 
thickened basal lamina, reduced myofiber thickness and an altered profile of 
secreted endocrine and paracrine factors. Collectively, these age-related extrinsic 
changes directly impact satellite cell function. 
 
Parabiotic studies by Brack et al. (2007) showed improved repair in skeletal muscle of 
old mice when the circulatory of system of old and young mice were linked. 
Conversely, skeletal muscle of young mice displayed decreased repair with satellite 
cells trans-differentiating to preferentially acquire a fibrogenic lineage. These results 
suggested that serum factors in the circulatory system regulate the regenerative 
capacity of satellite cells in the skeletal muscle in mice. Further analysis revealed that 
Wnt proteins in the serum of the old mice, specifically Wnt3a, play a pivotal role in 
the observed phenotypic change (Brack et al., 2007). Taken together, a combination 
of age-related changes in sarcopenic muscles itself, along with altered systemic 
factors control satellite cell fate and function. Moreover, parabiotic pairing 
experiment has demonstrated that the impaired myogenic differentiation capacity of 
satellite cells in aging muscle is reversible.   
 
The use of the in vitro culture system provides a powerful tool to examine the effect 
of external stimuli on a chosen cell population. The requirements for such study 
require the purification of these stimuli specifically signaling proteins. However, 
study and biochemical characterization of Wnt family of signaling proteins are 
hampered by their purification difficulty. Currently, only Wnt3a and 5a are purified in 
their active form from conditioned media (Kikuchi et al., 2007; Willert et al., 2003). 
These purified Wnt proteins allow an accurate in vitro assessment on the role of 
these Wnts on the cells of interest. Muroyama et al. (2004) demonstrated the 
addition of purified Wnt3a enhanced the differentiation of neural stem cells into 
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neurons and astroglias. Other studies have shown that the presence of purified 
Wnt3a in hematopoietic stem cell culture promoted proliferation and reduced 
differentiation (Willert et al., 2003). Alternatively, other methods are favored to 
study the effect of Wnt proteins due to their purification difficulty. These include 
co-culturing with transfected cell line or using conditioned media (CM) which provide 
an alternative source of Wnt proteins. Co-culturing of non-myogenic CD45+ cells with 
the transfected AtT-20 cell lines that expresses high levels of Wnt5a, 5b, 7a and 7b 
mix, induces myogenic lineage commitment of CD45+ cells (Polesskaya et al., 2003). 
Willert et al. (2003) utilized mouse L cell fibroblast to generate Wnt3a-CM to examine 
the effect of Wnt3a on the hematopoietic stem cells and Cha and Heasman (2010), 
generated Wnt5a- and Wnt11-CM from oocytes to determine the effect of both and 
individual proteins on Wnt signaling in mouse L cell fibroblasts. Therefore, 
co-culturing and use of CM provides an alternative source of active proteins. This is 
particularly important with respect to the Wnt family of proteins which are not 
readily available commercially and difficult to purify in their active form. 
 
Elevated protein levels of some Wnt isoforms are known to play a role in reduced 
myogenic progression in aging muscles (Brack et al., 2007). Furthermore, analysis of 
the CM from our previous studies (Chapter 2) of the three key Wnt isoforms, we have 
established that early passage C2C12 cells secreted high Wnt7 and 10b levels during 
differentiation in the CM. This high level of secretion is associated with promoting 
differentiation in early passage cells. On the contrary, late passage cells displayed 
defective differentiation coupled with lower levels of Wnt7 and 10b secretion, 
specifically Wnt10b. From these finding, we hypothesize that the high levels of Wnt7 
and 10b in CM from differentiating early passage cells can restore myogenic 
differentiation of late passage cells. Thus, we expand our studies with the use of 
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these valuable CM from early and late passage cells. In our current study, we devised 
an in vitro protocol to analyze myogenic differentiation of late passage cells (‘old’ 
C2C12 cells) in response to CM collected from early passage C2C12 cells (‘young’ 
C2C12 cells), and vice versa. Similar to the in vivo parabiotic pairing counterpart, the 
aim of this study was to restore the differentiation capacity of late passage cells 
through the use of CM from early passage C2C12 cells.  
 
3.2 MATERIALS AND METHOD 
3.2.1 Cell culture 
Early (P13) and late passage (P33) murine C2C12 cells were maintained in growth 
medium containing Dulbecco’s Modified Eagle’s Medium (Sigma) supplemented with 
10% fetal bovine serum (Gibco), 2 mM L-glutamine (Sigma) and 1% 
Penicillin/Streptomycin (Highveld Biological) maintained in an Innova® CO-170 
CO2-incubator (New Brunswick) at 37 °C, 5% CO2. Cells were induced to differentiate 
when 80% confluent by substituting growth medium with differentiation medium 
containing Dulbecco’s Modified Eagle’s Medium (Sigma) supplemented with 1% 
horse serum (Sigma), 2 mM L-glutamine (Sigma) and 1% Penicillin/Streptomycin 
(Highveld Biological). The CM of early and late passage cells was collected at day 0 
(day 0-CM), 1 (day 1-CM), 2 (day 2-CM) and 3 (day 3-CM) during differentiation of 
early ‘young’ or late ‘old’ passage cells, respectively. These collected CM were 
filtered through 0.2 μm syringe filters to further sterilize and remove non-adherent 








3.2.2 Cross-over experiment and C2C12 protein lysate preparation 
Early ‘young’ passage C2C12 cells were plated into CM from proliferating late passage 
cells (‘old’ day 0-CM), conversely, late ‘old’ passage C2C12 cells were plated into CM 
from proliferating early passage cells (‘young’ day 0-CM), in 6 well plates at 400 000 
cells/well. Upon reaching 80% confluency, early and late passage cells were induced 
to differentiate by changing both ‘young’ and ‘old’ day 0-CM with differentiation 
inducing ‘young’ and ‘old’ day 1-CM. To further differentiate the cells, both ‘young’ 
and ‘old’ day 1-CM was substituted with ‘young’ and ‘old’ day 2-CM at day 2 of 
differentiation and at day 3 of differentiation, ‘young’ and ‘old’ day 2-CM was 
replaced with ‘young’ and ‘old’ day 3-CM (Fig. 3.1). Cells were harvested at different 
time points (day 0, 1 and 3), detached with trypsin-EDTA, lysed in RIPA buffer (Sigma) 
and protein inhibitor cocktail (Sigma, P8340), and sonicated for 5 seconds in 
eppendorf tubes submerged in ice. For controls, a similar protocol was designed with 
early and late passage C2C12 cells plated into conventional growth medium and 
differentiated with conventional differentiation medium and harvested at the same 








































Fig. 3.1: Experimental design of the cross-over conditioned media experiment 
Early and late passage C2C12 cells maintained in T75 flasks were plated into 6 well plates at 400 000 
cells/well (triplicate plates) into ‘old ‘and ‘young’ day 0-CM, respectively. Upon reaching 80% 
confluency, cells were harvested (day 0) and cells in the remaining wells were induced to differentiate 
with ‘young’ or ‘old’ day 1-CM. After 24 hour incubation, day 1 cells were harvested, remaining cells 
were treated with ‘young’ or ’old’ day 2-CM and further incubated for 24 hours. Thereafter, the media 
was substituted with ‘young’ or ‘old’ day 3-CM, incubated for 24 hours and subsequently harvested at 
day 3. Harvested cells were lysed and probed for MHC, Myogenin, Wnt3a and 7. Controls cells were 
treated with the conventional growth and differentiation medium. Experiment were performed in 
triplicates for each protein (n=3) for the cross-over and control treated cells. 
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3.2.3 Western blotting of C2C12 protein lysates 
Western blotting was used to monitor protein expression levels during proliferation 
and differentiation of C2C12 cells treated with CM. 30 μg of cross-over and control 
treated cell lysates (protein concentration determined by Bradford assay, section 
2.2.5) from each time point were resolved in a reducing 12.5% SDS-polyacrymide gel 
at 18 mA/gel (Laemmli, 1970). Thereafter, nitrocellulose membrane was incubated 
with primary antibodies against MHC (MF 20,Hybridoma Bank), Myogenin (F5D, 
Santa Cruz), Wnt3a (YY-7, Santa Cruz), Wnt7 (H-40, Santa Cruz), and internal controls, 
α-tubulin (B-7, Santa Cruz) and GAPDH (14C10, Cell Signaling) in TTBS (see section 
2.2.1, Table 2.3, for optimized primary antibody dilutions), overnight at 4 °C. 
Following primary antibody incubation, the nitrocellulose membrane was washed 
and incubated in secondary HRP-linked antibodies in TTBS (see section 2.2.1, Table 
2.2, for secondary antibody dilutions) (1 hour), at room temperature. The 
antigen-antibody complex was visualized using an ECL kit (Immun-Star™ WesternC™ 
Chemiluminescent Kit, BioRad) according to manufacturer’s instructions. The 
nitrocellulose membranes were exposed onto Biomax light film (Kodak) and 
captured on VersaDoc™ MP imager (BioRad). Densitometry analysis for protein 
expression levels were quantified with Quantity One software (BioRad) by tracing 
around the band of interest.  
 
3.2.4. Statistical analysis 
For statistical purpose, each experiment were performed a minimum of 3 to 9 
replicates (n=3 for MHC, Myogenin, Wnt 3a and 7 expression analysis; n=6 for 
α-tubulin expression analysis; n=9 for GAPDH expression analysis). All data are 
represented as mean ±SEM (standard error of the mean). The paired Student’s t-test 
was performed for parametric data and paired Mann-Whitney U test for 
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non-parametric data. All statistical tests were performed using the Genstat 12th 
edition statistical software (VSN International). Differences in data sets were 
considered significant if p < 0.05. 
 
3.3 RESULTS 
3.3.1 Expression levels of α-tubulin and GAPDH in response to conditioned 
differentiation media 
Equal loading of cell lysates is essential to accurately determine changes in protein 
expression. House-keeping genes such as α-tubulin, β-tubulin, GAPDH and β-actin 
that are constitutively expressed regardless of different treatments are often probed 
together with the protein of interest to ensure such equal protein loading. However, 
the expression of these house-keeping genes has been shown to change under 
certain conditions such as fluctuations in cell confluency even when equivalent loads 
of proteins lysates are analyzed (Dittmer and Dittmer, 2006; Greer et al., 2010). In 
section 2.3.4, we determined that the expression of α-tubulin and GAPDH remained 
constant during differentiation of early and late passage C2C12 cells. Here, we sought 
to determine whether CM changed the expression of α-tubulin or GAPDH during 
differentiation within early and late passage and further compared both proteins 
between the two passages. As expected, no fluctuations were seen in differentiating 
cells under control conditions (Fig. 3.2B and 3.3B). The results of the cross-over 
treated cells indicated that within both differentiating early and late passage cells, 
α-tubulin and GAPDH expression levels fluctuated but no significant difference were 
observed. However, late passage cells treated with ‘young’ media showed a decrease 
in the expression profile of α-tubulin along with a significant increase in GAPDH 
compared to early passage expression of both proteins (Fig. 3.2A and 3.3A). 
Therefore, although treating cells with the conditioned media did not change the 
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levels of both house-keeping genes (α-tubulin and GAPDH) within each passage, 
fluctuations were observed. Furthermore, significant differences between passages 
were seen and due to these fluctuations, ponceau S staining was rather used to 




















































Fig. 3.2: Expression of α-tubulin during C2C12 cell differentiation 
The expression of α-tubulin from western blotting was compared during differentiation in cross-over 
and control treated C2C12 cells. Early and late passage cells were plated into ‘old’ or ‘young’ day 0-CM. 
Upon reaching 80% confluency, cells were induced to differentiate by replacing day 0-CM with ‘young’ 
or ‘old’ day 1-CM and further differentiated with ‘young’ or ‘old’ day 2- and day 3-CM. Cells were 
harvested at days 0, 1 and 3, and probed for α-tubulin via western blotting (C and D). Densitometry 
values were determined in early and late passage cells treated with CM (A) and controls (B), 
respectively. Ponceau stain was used to confirm equal loading. Reduced α-tubulin levels in the late 
passage cells from cross-over treated cells were observed with no difference in α-tubulin levels in 
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Fig. 3.3: GAPDH expression levels of differentiating C2C12 cells 
The expression of GAPDH from western blotting was compared during differentiation in cross-over 
and control treated C2C12 cells. Early and late passage cells were plated into ‘old’ or ‘young’ day 0-CM. 
Upon reaching 80% confluency, cells were induced to differentiate by replacing day 0-CM with ‘young’ 
or ‘old’ day 1-CM and further differentiated with ‘young’ or ‘old’ day 2- and day 3-CM. Cells were 
harvested at days 0, 1 and 3, and probed for GAPDH via western blotting (C and D). Densitometry 
values were determined in early and late passage cells treated with CM (A) and controls (B), 
respectively. Ponceau stain was used to confirm equal loading. Elevated GAPDH levels in the late 
passage cells from cross-over treated cells were observed. Experiment performed in 9 replicates (n=9) 
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3.3.2 Total Myogenin and MHC levels in response to differentiation conditioned 
media in C2C12 cells 
Previously (Chapter 2), we established that late passage C2C12 cells lack myogenic 
differentiation capacity reflected in part by reduced Myogenin expression levels 
(section 2.3.5). In the current study, we utilized Myogenin and Myosin heavy chain, 
also a marker of myogenic progression (Bader et al., 1982), to analyze the state of 
myogenic differentiation in differentiating C2C12 cells in the cross-over experiment. 
Likewise, in this chapter, late passage cells under control conditions displayed poor 
differentiation capacity with down-regulated Myogenin levels and conversely, early 
passage cells displayed effective differentiation with up-regulated Myogenin levels 
(Fig. 3.4A and C). This lack of differentiation capacity in late passage cells was further 
confirmed by reduced MHC expression profile in the control cells (Fig. 3.5A and C). 
Treatment of early passage cells with ‘old’ media did not reduce the level of 
Myogenin and MHC but surprisingly had elevated the levels of both proteins, along 
with a significant increase of MHC levels at day 1 (Fig. 3.5A), relative to control levels. 
Late passage cells with the characteristic impaired differentiation, when cultured in 
the presence of ‘young’ media, displayed up-regulated Myogenin and MHC levels, 
with a significant increase of MHC expression at day 1 and 3 (Fig. 3.5A). Lastly, 
besides the differences in levels of Myogenin and MHC regardless of the different 
C2C12 cell treatments, an increasing trend of both proteins was observed with time. 
This characteristic trend was also prevalent in our previous study (Chapter 2). In 
summary, secreted factors in ‘young’ media resulted in higher Myogenin and MHC 
expression in differentiation poor late passage cells. These elevated levels could 
indicate that ‘young’ media could have rejuvenated late passage cells to undergo 



















Fig. 3.4: Myogenin expression profile of differentiating C2C12 cells 
The expression of Myogenin was compared during differentiation in cross-over and control treated 
C2C12 cells. Early and late passage cells were plated into ‘old’ or ‘young’ day 0-CM. Upon reaching 
80% confluency, cells were induced to differentiate by replacing day 0-CM with ‘young’ or ‘old’ day 
1-CM and further differentiated with ‘young’ or ‘old’ day 2- and day 3-CM. Cells were harvested at 
days 0, 1 and 3, and probed for Myogenin, and densitometry values (A) were determined from 
western blotting in early and late passage cells treated with CM (B) and the controls (C), respectively. 
Late passage cells treated with ‘young’ media indicated a higher expression of Myogenin which 
suggest myogenic differentiation improvement; however no difference in levels of Myogenin in early 
passage cells treated with ‘old’ media was observed when both are compared to the respective 






































Days in differentiation medium 
Early passage (in 'old' media) Early passage (control)
Late passage (in 'young' media) Late passage (control)
day 0   1     3  
Cross-over treatment Control 
day 0   1     3  
day 0   1     3  
day 0   1     3  
Early passage (in ‘old’ media) 
Late passage (in ‘young’ media) 
Early passage (control) 




























Fig. 3.5: MHC expression profile of differentiating C2C12 cells 
The expression of MHC was compared during differentiation in cross-over and control treated C2C12 
cells. Early and late passage cells were plated into ‘old’ or ‘young’ day 0-CM. Upon reaching 80% 
confluency, cells were induced to differentiate by replacing day 0-CM with ‘young’ or ‘old’ day 1-CM 
and further differentiated with ‘young’ or ‘old’ day 2- and day 3-CM. Cells were harvested at days 0, 1 
and 3, and probed for MHC, and densitometry values (A) were determined from western blotting in 
early and late passage cells treated with CM (B) and the controls (C), respectively. Late passage cells 
treated with ‘young’ media has a higher expression of MHC compared to the respective control which 
suggests myogenic differentiation improvement. However, MHC levels in early passage cells treated 
with ‘old’ media had higher expression initially at day 1. Experiment performed in 3 replicates (n=3) 





































Days in differentiation medium 
Early passage (in 'old' media) Early passage (control)
Late passage (in 'young' media) Late passage (control)
day 0   1     3  
Early passage (in ‘old’ media) 
Late passage (in ‘young’ media) 
Early passage (control) 
Late passage (control) 
Cross-over treatment Control 
day 0   1     3  
day 0   1     3  
day 0   1     3  
* * * 
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3.3.3 Analysis of cytosolic Wnt levels in response to differentiation conditioned 
media in C2C12 cells 
In Chapter 2, we have established that late passage C2C12 cells displayed high 
cytosolic Wnt3a expression which supports the elevated myogenic to fibrotic lineage 
conversion, and a rapid decline in Wnt7 expression. Both characteristic expressions 
are associated with the lack of myogenic differentiation in late passage cells. To 
determine the levels of Wnts produced in response to differentiating CM, all results 
of Wnt expression following addition of differentiating CM were normalized to day 0 
by subtracting densitometry data at day 0 from day 1 and 3. Results were presented 
as the change in expression relative to day 0. Interestingly, late passage cells treated 
with ‘young’ media displayed a suppression of Wnt3a levels at day 1; however this 
suppression is lost at day 3 where Wnt3a levels were significantly higher compared to 
the control (Fig. 3.6A). Early passage cells treated with ‘old’ media was expected to 
increase Wnt3a levels. Indeed, this was observed at day 1 but at day 3, control levels 
surpassed the cross-over treated early passage cells. Therefore, secreted factors in 
‘young’ and ‘old’ media initially at day 1 suppressed Wnt3a expression in late passage 
cells and elevated Wnt3a expression in early passage cells, respectively. However, 
these expression levels at day 1 did not persist to day 3. The Wnt7 profile altered 
dramatically in the cross-over treated cells. Late passage cells treated with ‘young’ 
media had an elevated expression profile whereas early passage cells treated with 
‘old’ media displayed a reduced level of Wnt7, with a significant reduction at day 3, in 
comparison to the respective controls (Fig. 3.7A). Therefore, secreted factors in 
‘young’ media altered Wnt7 levels of late passage cells which acquired increasing 
Wnt7 levels associated with effective myogenic differentiation, whereas early 
passage cells acquired low and decreasing levels of Wnt7 in the presence of secreted 




























Fig. 3.6: Wnt3a expression profile of C2C12 cells in response to conditioned media  
The expression of Wnt3a was compared during differentiation in cross-over and control treated C2C12 
cells. Early and late passage cells were plated into ‘old’ or ‘young’ day 0-CM. Upon reaching 80% 
confluency, cells were induced to differentiate by replacing day 0-CM with ‘young’ or ‘old’ day 1-CM 
and further differentiated with ‘young’ or ‘old’ day 2- and day 3-CM. Cells were harvested at days 0, 1 
and 3, and probed for Wnt3a, and densitometry values (A) were determined from western blotting in 
early and late passage cells treated with CM (B) and the controls (C), respectively. Compared to the 
controls, early passage cells treated with ‘old’ media had higher Wnt3a level at day 1 but lower at day 
3; on the other hand, late passage cells treated with ‘young’ media displayed lower Wnt3a levels at 
day 1 but higher levels at day 3. The latter seem to indicate suppression of fibrosis by ‘young’ media 
on late passage cells at day 1 but this suppression is eventually loss at day 3 of differentiation. 






















































Days in differentiation medium 
Early passage (in 'old' media) Early passage (control)
Late passage (in 'young' media) Late passage (control)
day 0   1     3  
Cross-over treatment Control 
day 0   1     3  
day 0   1     3  
day 0   1     3  
* 
Early passage (in ‘old’ media) 
Late passage (in ‘young’ media) 
Early passage (control) 




























Fig. 3.7: Wnt7 expression profile of C2C12 cells in response to conditioned media 
The expression of Wnt7 was compared during differentiation in cross-over and control treated C2C12 
cells. Early and late passage cells were plated into ‘old’ or ‘young’ day 0-CM. Upon reaching 80% 
confluency, cells were induced to differentiate by replacing day 0-CM with ‘young’ or ‘old’ day 1-CM 
and further differentiated with ‘young’ or ‘old’ day 2- and day 3-CM. Cells were harvested at days 0, 1 
and 3, and probed for Wnt7 and densitometry values (A) were determined from western blotting in 
early and late passage cells treated with CM (B) and the controls (C), respectively. Early passage cells 
treated with ‘old’ media had a declining Wnt7 level, whereas late passage cells treated with ‘young’ 
media, an increasing Wnt7 level during differentiation. These contrary trends in the cross-over treated 
cells to the controls seem to indicate an improvement to myogenesis. Experiment performed in 3 





















































Days in differentiation medium 
Early passage (in 'old' media) Early passage (control)
Late passage (in 'young' media) Late passage (control)
day 0   1     3  
Cross-over treatment Control 
day 0   1     3  
day 0   1     3  
day 0   1     3  
* 
Early passage (in ‘old’ media) 
Late passage (in ‘young’ media) 
Early passage (control) 




In Chapter 2, we reported the baseline expression of Wnt3a, 7 and 10b in early and 
late passage C2C12 cells. The results indicated that early passage cells secreted high 
levels of Wnt3a and 7 and conversely, low levels of Wnt3a and 7 in the late passage 
cells. Thus, we hypothesize that the early and late passage C2C12 cells conditioned 
the surrounding media with the secreted Wnts to either promote or impede 
differentiation. To test this hypothesis, we harvested the early and late passage 
C2C12 cells treated with CM and analyzed the myogenic capacity in response to the 
CM.  
 
Expression of house-keeping genes has been shown to change making them 
unreliable as internal controls. Dittmer and Dittmer (2006) noted with high protein 
loading for the detection of low-abundance protein, no difference in signal intensity 
was observed. Furthermore, Greer et al. (2010) demonstrated that cell confluency 
affects α-tubulin and GAPDH levels even when equivalent loads of protein are 
analyzed. Likewise, we observed expression differences in our internal controls when 
differentiating early passage cells was compared to differentiating late passage cells. 
This makes normalizing to both internal controls for the expression comparison 
between early and late C2C12 passage cells for the protein of interest unreliable. 
However, from our Chapter 2, expressions of bothα-tubulin and GAPDH did not 
change within early and late passage cells in the individual differentiation 
experiments. Therefore, we utilized both internal controls and ponceau stained blots 
as an indication of equal loading within early and late passage cells in response to 
differentiation. 
 
Wnt proteins are known to be difficult to purify in their active form due to their 
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hydrophobic properties (Kikuchi et al., 2007). Therefore, CM from transfected cells to 
generate Wnt-CM or normal cell lines to generate CM containing Wnts, provide an 
alternative approach to study the effect of Wnt secreted proteins on the cells of 
interest. In our current study, we utilized the latter method to generate media from 
early passage cells to promote differentiation in late passage C2C12 cells which in 
chapter 2, we determined to have reduced myogenic capacity. Our results indicated 
that late passage cells treated with ‘young’ media had higher Myogenin and MHC 
levels but surprisingly, a slight increase in levels of both proteins in early passage cells 
was seen when treated with ‘old’ media, compared to their respective controls. 
Contradictorily, secreted factors in ‘young’ and ‘old’ media seem to both promote 
differentiation in late and early passage cells. Studying the effects of CM on the cells 
of interest is known to yield contradictory results to cells treated with purified 
proteins. Willert et al. (2003) indicated that Wnt 3a-conditioned media promoted 
differentiation in hematopoietic stem cell cultures whereas addition of purified 
Wnt3a protein reduced differentiation and promoted proliferation. They concluded 
that other factors in the conditioned media promoted differentiation rather than 
proliferation. Densitometry values indicate an increase in MHC levels in late passage 
cells treated with ‘young’ media, it should be noted from the MHC blots that signal 
bands were very faint; therefore the increase in levels is most likely to be a result of 
background values and therefore should be taken with caution. To overcome this 
dilemma, an increase in cell protein lysates loading coupled with an increase in film 
exposure could possibly result in an elevated signal. Lastly, we noted a possible 
mobility shift in Myogenin in both early passage cells treated with ‘old’ media and 
early passage cells under control conditions. This increase in molecular weight (at 
day 3) is likely due to the phosphorylation of Myogenin at Threonine-87 (Blagden et 




Wnt3a and 7 expression levels were significantly affected by conditioned media. This 
increase in both Wnt3a and 7 also observed in the Chapter 2 signifies a possible role 
of both Wnt isoforms in myogenic differentiation. Indeed, Polesskaya et al. (2003) 
and Brack et al. (2008) reported that Wnt7a and b, and Wnt3a mRNA transcript level 
increases in regenerating muscle, respectively. However, high elevated Wnt3a has 
been shown to promote fibrosis (Brack et al., 2007). Therefore, we hypothesized that 
‘young’ media would reduce the Wnt3a levels to suppress fibrosis. Indeed, at day 1 
of differentiation, ‘young’ media reduced the Wnt3a levels in late passage C2C12 
cells and ‘old’ media elevated the Wnt3a levels. However, similar results were not 
carried to day 3. At day 3, levels of Wnt3a in cross-over treated early passage cells 
remained at the same level as day 1 but late passage cells had a sudden increase 
which was significantly higher compared to the control treated cells. Therefore, 
secreted factors from ‘young’ media initially suppressed Wnt3a levels in late passage 
cells and ‘old’ media elevated Wnt3a levels in early passage cells at day 1, however 
these effects are lost at day 3. This suggests that Wnt3a alone may not be 
responsible for the decline in differentiation seen in late passage cells. 
 
Results from Chapter 2 showed that Wnt7 levels decline and increases in 
differentiating late and early passage C2C12 cells, respectively. These decreasing 
trends coincided with poor differentiation in late passage cells and vice versa. 
Furthermore, we determined the importance of Wnt7 in myogenic differentiation 
and concluded the possible use of Wnt7 proteins to promote myogenesis in 
myogenic deficient muscle such as muscular dystrophy. Interestingly, Wnt7 
expression profile changed in our cross-over treated compared to the control treated 
cells, with early passage cells treated with ‘old’ media acquired a reduced Wnt7 
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expression, whereas late passage treated with ‘young’ media, acquired an increase 
of Wnt7. These results suggest that Wnt7 could play a role in altering the 
differentiation phenotype in late passage cells. Given the importance of Wnt10b 
(together with Wnt7), it would be interesting to additionally analyze Wnt10b levels in 
our cross-over treated C2C12 cell lysates. 
 
In our study, we did not extend the differentiation period post-day 3 because the 
collected CM post-day 3 changed in pH which could have a negative effect on the 
C2C12 cell differentiation. Therefore, by extending the days of differentiation 
post-day 3, a more pronounced outcome of Myogenin and MHC levels might be 
possible. Furthermore, Wnt protein secretion levels are known to be very low 
(Bradley and Brown, 1995), therefore the failure of ‘young’ media to dramatically 
improve the differentiation of late passage cells could also be attributed to the 
insufficient levels of Wnt proteins in the CM. Alternatively, conditioned media by 
transfected cell line to over-express Wnts3a and 7 could be used to increase the 
levels of these particular differentiation-inducing Wnts. Polesskaya et al. (2003) 
utilized this co-culture method to generate CM containing high levels of Wnts5a, 5b, 
7a and 7b by transfecting AtT-20 cell line to over-express these Wnt isoforms. The 
CM utilized in our studies took a long period to generate and further utilized for the 
cross-over treatment of C2C12 cells thus could run a risk of protein degradation due 
to this extended period of use in culture. To prevent protein degradation, co-culture 
with a transfected cell line could further be utilized to provide a constant supply of 
paracrine Wnt proteins to the cells of interest.  
 
In summary, Wnt-conditioned media has been used extensively to study the effects 
of Wnts on cells. However, results are sometimes ambiguous due to the presence of 
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other secreted factors. Furthermore, we utilized a cell line that has a corrupt cell 
cycle by accumulated mutations in culture. These mutations could intrinsically alter 
the cells to be less susceptible to the surrounding secreted factors. Analysis of 
differentiation in the cross-over experiment should therefore be repeated with 
primary culture myoblasts. Also it should be noted that the expression profile of 
Wnt7 changed significantly which could indicate myogenic improvement. Thus, until 
more Wnt proteins are purified, alternative methods to generate CM with higher 
concentrations of desired Wnt proteins using transfected cell lines or co-culture 























Satellite cells reside between the sarcolemma and basal lamina of myofibers and are 
responsible for the maintenance and repair of skeletal muscle (Charge and Rudnicki, 
2004). This efficient myogenic process declines with age, typified by the 
accumulation of adipocytes and fibroblasts, and the accumulation of scar tissue upon 
injury. The age-related extrinsic and intrinsic changes in aging muscles have 
collectively been shown to negatively impact satellite cell myogenesis. Parabiotic 
studies where the circulatory systems of young and old mice are linked implied that 
satellite cells in old mice can be rejuvenated to undergo effective myogenesis by the 
exposure to a youthful environment. In addition, the study showed that at least one 
of the causes of the age-related decline in myogenesis was due to elevated canonical 
Wnt signaling by serum factors, likely by Wnt3a protein. Although the Wnt mRNA 
levels during myogenesis have been well documented, the relevant Wnt protein 
levels had not been quantified. Thus, our study aimed to establish the cytosolic and 
secreted protein profiles of three chosen Wnts, namely Wnt3a, 7 and 10b, in early 
and late passage C2C12 cells. 
 
Following satellite cell activation, MyoD is expressed, which in turn facilitates 
Myogenin expression as the myogenic lineage progresses. MyoD-/- myoblasts from 
muscles of MyoD knock-out mice continued to proliferate when cultured in 
differentiation medium, however they fail to differentiate; this lack of differentiation 
is associated with the suppressed downstream expression of Myogenin (Sabourin et 
al., 1999). Restoring MyoD with MyoD expressing vector in MyoD-/- myoblasts 
resulted in effective differentiation and successful Myogenin expression, therefore 
the expression is dependent on the transcriptional activity of MyoD. The loss in 
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differentiation capacity of MyoD-/- myoblasts was also observed in our late passage 
C2C12 cells which continued proliferating in differentiation medium. However, total 
MyoD levels were higher in the late vs. early passage cells; therefore it is more likely 
that the failure to differentiate is possibly caused by the repressed activity of MyoD 
by co-repressors, protein stability or protein modifications, and not due to the total 
levels.  
 
Indeed, modifications of histones and MyoD were shown to play a central role in this 
regulation. Mal and Harter (2003) indicated that histone deacetylase (HDAC) 
complexes with MyoD at the promoter site of Myogenin, and deacetylates H3 
histone which subsequently silences Myogenin. Gillespie et al. (2009) indicated that 
the absence of p38γ, MyoD is not phosphorylated and in this conformation, KMT1A 
methyltransferase is not recruited and histone H3K9 methylation is absent which 
leads to the premature expression of Myogenin. It is possible that both proposed 
mechanisms are involved in the suppression and activation of MyoD activity. To 
experimentally verify this in our early and late passage C2C12 cells; chromatin 
immuo-precipitation (ChIP) assay with the relevant antibodies against HADC and 
KMT1A methyltransferase could be assessed. In addition, the p38γ levels between 
the two passages could be quantified during differentiation. The molecular 
repression and activation activity of MyoD can be seen with our early and late 
passage cells with the expression profile of Myogenin. As Myogenin expression is 
dependent on MyoD activity, the rise in Myogenin levels suggests that MyoD activity 
occurred which was seen in our early passage cells. On the other hand, the low levels 
of Myogenin in late passage cells suggest repression of MyoD. Therefore, these 
molecular events signify that protein modification and the activity of repressors are 
just as important as protein levels. It is interesting to note that levels of MyoD and 
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Myogenin have been shown to be higher in muscles of old senile rats when 
compared with their younger counterparts which agrees with our MyoD results 
(Dedkov et al., 2003).  
 
In young muscle, Notch and Wnt signaling have been indicated to regulate 
proliferation and differentiation, respectively (Brack et al., 2008; Conboy and Rando, 
2002). The cross-talk between the two processes is mediated by GSK-3β; therefore 
the onset of differentiation requires the up-regulation of Wnt signaling by inhibiting 





Fig. 4.1: The balance between proliferation and differentiation in early and late passage C2C12 cells 
The balance between proliferation and differentiation requires the cross-talk of Wnt with Notch 
signaling, mediated by the common target protein, GSK-3β. Early passage C2C12 cells could 
up-regulate Wnt signaling by inhibiting the activity of GSK-3β to readily undergo differentiation in 
differentiation medium and in the process, down-regulate Notch signaling. On the contrary, late 
passage C2C12 cells could activate GSK-3β which results in the up-regulation of Notch signaling and 
down-regulation Wnt signaling, and continued proliferating in differentiation medium. Therefore, we 
speculate that the increase in passage numbers likely tilted the balance towards Notch signaling even 
under differentiation conditions and resulted in the continued proliferation seen in our late passage 




Indeed, quantification of Wnt3a, 7a and 7b transcripts during muscle regeneration 
has been shown to increase in regenerating muscle (Brack et al., 2008; Polesskaya et 
al., 2003). In agreement, Wnt expression profiles of all three Wnt isoforms during 
differentiation showed an overall increase, specifically with the differentiation 
competent early passage C2C12 cells. Therefore, the increase in mRNA transcripts 
would likely reflect the protein levels. To verify this, mRNA transcript levels of our 
three Wnt isoforms should be further analyzed with RT-PCR. It is interesting to note 
that the injection of endogenous Wnt3a into regenerating young muscle resulted in 
poor skeletal muscle repair (Brack et al., 2007). These results could rise from the 
early onset of differentiation by the premature induction of Wnt signaling by the 
suppression of Notch signaling. Therefore, the premature up-regulation of Wnt 
signaling could impede myogenesis. From these accumulated data, the progression 
of myogenesis requires the temporal balance between Notch and Wnt signaling 
through the stages of proliferation to differentiation, respectively. It is likely that in 
aging muscle, this temporal regulation is lost and that the switch from Notch to Wnt 
signaling does not occur correctly. An evidence of this imbalance was seen in our 
early vs. late passage cells. Our early passage cells were differentiation competent 
when provided with differentiation cues whereas the late passage cells were 
incapable of differentiation, and continued proliferating in the presence of 
differentiation cues (Fig. 4.1). Therefore, we speculate that our early passage C2C12 
cells down-regulate Notch and when induced to differentiate, and up-regulate Wnt 
signaling. However, in the late passage cells, this switch from Notch to Wnt signaling 
could be lost. Analysis of our chosen canonical Wnt proteins provided some insight 
into this imbalance, specifically Wnt7. All three isoforms in the early passage C2C12 
cells showed an overall increase in progression of differentiation, however in late 
passage cells, a rapid decline in Wnt7 and lower Wnt10b levels was observed. This 
105 
 
rapid decline in Wnt7 and low Wnt10b expression is likely associated with the down- 
and up-regulation of the Wnt and Notch signaling, respectively. Therefore, to verify 
this imbalance at the molecular level, down-stream target of both pathways such as 
GSK-3β can be quantified during proliferation (at day 0) and during differentiation in 
early and late passage cells, along with markers of proliferation (Ki-67) and 
differentiation (MyoD and Myogenin). We hypothesize that during proliferation of 
early passage cells, GSK-3β levels would be elevated and upon the induction of 
differentiation, GSK-3β levels would gradually decline. However, in late passage cells, 
GSK-3β levels could remain elevated during proliferation and differentiation. Together, 
cross-talk between Notch and Wnt signaling is required for effective differentiation 
and our results indicate that Wnt7 could be a key isoform in regulating this transition. 
 
Analysis of canonical Wnt3a protein during differentiation showed an overall higher 
and rapid expression in late passage C2C12 cells. These results may seem 
counterintuitive as Wnt3a also induces canonical Wnt signaling required for effective 
differentiation. However, seminal work by Brack et al. (2007) demonstrated that 
elevated Wnt3a signaling accounted for the poor myogenesis observed as well as 
accumulated tissue fibrosis. However, from the Wnt7 data (early vs. late passage), we 
derived that a gradual increase in Wnt signaling during differentiation is required. 
Therefore, the sudden rise in Wnt3a observed in late passage cells could induce Wnt 
signaling prematurely leading to impaired myogenesis. The lineage alteration 
suggested by Brack et al. (2007) was not performed in our study. It would therefore 
be interesting to assay for this lineage change with fibroblast specific marker, ER-TR7. 
Overall, it may appear that Wnt signaling leads to a disastrous effect on myogenesis 
from the Wnt3a data, but from the Wnt7 data, it appears that a gradual 
up-regulation of Wnt signaling is required for successful differentiation.  
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Wnt10b has been suggested to play a role in a myogenic to adipogenic lineage 
conversion via the canonical Wnt signaling with age. The Wnt10b mRNA transcript 
levels were shown to increase in the presence of cyclic mechanical stretching 
(Akimoto et al., 2005). This mechanical stretch inhibited the myogenic to adipogenic 
fate in C2C12 cells along with elevated Wnt10b mRNA transcript. Furthermore, the 
down-regulation of canonical Wnt signaling by inactivating TCF/LEF lead to an 
adipogenic conversion in C2C12 and G8 myoblast cell lines verified by Oil Red-O 
staining (Ross et al., 2000). These data seem to suggest that the balance between 
myogenic and adipogenic potential in myoblasts is controlled Wnt signaling. In aging 
muscle, this balance seems to be shifted towards adipogenesis by down-regulating 
Wnt signaling. Comparison of Wnt10b mRNA levels showed higher transcripts in 
muscles of young mice than old mice (Taylor-Jones et al., 2002). Our Wnt10b 
cytosolic analysis correlates with the Wnt10b transcript levels with the early passage 
C2C12 cells showing an overall elevated Wnt10b protein expression. This would likely 
prevent adipogenesis lineage conversion by up-regulating Wnt signaling. On the 
contrary, late passage cells showed an overall reduction in Wnt10b expression, thus 
possibly displaying an adipogenic propensity. The adipogenic propensity was not 
determined in our cells; however this can be simply determined with Red-O staining. 
From these data, it seems likely that the up-regulation of Wnt signaling by Wnt10b is 
required to prevent adipogenic lineage alteration in young muscle. Lastly, knock-out 
studies of Wnt10b (Wnt10b-/-) in mice have provided insight to the complex 
interactive roles of multiple Wnts in myogenesis. Wnt10b-/- myoblasts from muscle of 
young knock-out mice differentiated effectively due to the compensation effect of 
Wnt7, conversely, this compensation action is lost with age in old Wnt10b-/- 
myoblasts. This compensation by Wnt7 is seen in our study in the early period of 
differentiation, but is eventually lost. This study agrees with our finding that Wnt7 is 
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the likely key isoform for myogenic differentiation, Wnt10b for adipogenesis and 




Fig. 4.2: The proposed role of Wnt isoforms in lineage specification of C2C12 myoblasts   
C2C12 cells undergo successful myogenesis with the formation of myotubes. However, the increase in 
passage negatively affects myogenesis with the increase in fibrogenesis and adipogenesis propensity 
which is likely mediated by Wnt proteins. Early passage cells undergo effective differentiation with the 
up-regulation of Wnt7 and the down-regulation of Wnt3a. On the other hand, late passage cells 
showed reduced myogenesis with a declining Wnt7, lower Wnt10b and high Wnt3a levels. The 
down-regulated Wnt10b and up-regulated Wnt3a levels are likely associated with fibrogenesis and 
adipogenesis in late passage cells, respectively. Furthermore, the declining levels of Wnt7 in late 
passage cells reflect the decline in myogenesis. 
 
Next, we quantified the secreted Wnt3a, 7 and 10b levels during differentiation. This 
novel analysis of the three Wnt isoforms in CM revealed the presence of secreted 
Wnt proteins only in CM from differentiating, not proliferating C2C12 cells. Overall, 
we observed a higher secretion of Wnt7 in comparison to Wnt3a and 10b and a 
characteristic trend in secretion, similar to the cytosolic expression – early passage 
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C2C12 cells displayed an increase in secretion whereas late passage cells had a 
rapidly declining secretion. Surprisingly, when we determined the ratio of secreted to 
cytosolic production of the three Wnts between early and late passage cells, early 
passage cells displayed a higher ratio in all Wnt isoforms, with the highest seen in 
Wnt7. These values indicate that early passage cells have a higher tendency to 
secrete Wnts than late passage cells. The reason for the lack of secretion in late 
passage cells is unknown. Post-modifications of Wnt proteins involve both 
palmitoylation and glycosylation. Palmitoylation has been shown to be important for 
active signaling, but not essential for secretion (Willert et al., 2003), however 
glycosylation is required for proper protein folding which is a requirement for protein 
secretion (Kikuchi et al., 2007). Thus, late passage cells could have defective 
machinery for glycosylation. Nevertheless, it is clear that further characterization of 
Wnt proteins is required. Lastly, a high Wnt7 ratio of secretion to cytosolic levels was 
observed in our studies. From the data in the cytosolic expression profiles, we 
established that Wnt7 play a role in myogenesis. Therefore, high secretion of Wnt7 
could reflect the propensity of C2C12 cells, especially early passage cells, to undergo 
myogenesis. 
 
Following the analysis of the secreted levels, we hypothesized that the secreted Wnt 
proteins in early passage C2C12 cells would be able to rescue the myogenic capacity 
of late passage cells. However, in the cross-over treatment of C2C12 cells, we did not 
observe an improvement in myogenesis in late passage cells when treated with CM 
from early passage cells. CM contains many secreted factors which may include 
TGF-β as well as secreted Wnt antagonists. TGF-β1 has been indicated to be elevated 
in the serum of aging mice and shown to have an inhibitory effect on myogenesis 
(Carlson et al., 2009). Wnt antagonists are divided into two classes. One class directly 
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binds to Wnts and prevents ligand-receptor interaction which includes secreted 
Frizzled-related protein (sFRP), Wnt inhibitory factor (WIF) and Cerberus (Kawano 
and Kypta, 2003). And the other binds LRP5/6 co-receptor and prevents the 
Frizzled-LRP5/6 formation and includes Dickkopf (Dkk) (Kawano and Kypta, 2003). 
Therefore, the possible presence of these secreted antagonists and TGF-β in CM of 
early passage cells could potentially antagonize Wnt signaling and suppress 
myogenesis in late passage cells. Besides the secreted antagonists, it has also been 
shown that the regulation of Wnt signaling can be receptor dependent (Mikels and 
Nusse, 2006). Therefore, it is possible that receptors specific to Wnt3a and 7 are not 
expressed in early passage cells, therefore Wnt signaling is inactivated. Furthermore, 
Wnt proteins are known to be secreted inefficiently. It is likely that the secretion of 
Wnt isoforms in our CM was very low. Using CM from transfected cell lines that 
over-express Wnt proteins could provide a better yield of secreted Wnts. 
 
Interestingly, the expression profile of Wnt7 was dramatically altered with the early 
passage cells acquiring a declining expression when treated with ‘old-CM’ whereas 
the late passage cells acquired an increasing expression treated with ‘young-CM’. 
This change in expression pattern does suggest myogenesis was improved in late 
passage cells. It is interesting to note that ratio of Wnt10 secretion to cytosolic levels 
showed a several fold increase in early compared to late passage cells. Therefore, 
further analysis could include Wnt10b that might yield a different expression of 
Wnt10b. 
 
Finally, our analysis of protein levels was conducted using C2C12 myoblast cell line. 
Cell lines by nature are immortal due to the accumulated mutations which could 
alter growth factor receptors, leading to an altered response to these factors. 
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Therefore, the experiments of this study should be repeated with primary cultures. In 
summary, our data has generated insight to the roles of Wnt3a, 7 and 10b isoforms 
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Oil 
Microwave Sample Preparation Note: XprOP-! 
Category: Oils 
Rev. Date: 6/04 
Sample Type: Oil 
Application Type: Acid Digestion 
Vessel Type: 55 mL 
Number of Vessels: 12 
Reagents: Nitric Acid (70%) 
Method Sample Type: Organic 








Pressure (psi) I T ernpera!ure (°C 
200 
~OTT. A~ lh!s p;ocedure !s. a refereooe point for sampic dige.'>tio-n using the CEJi..1 t\1 i.;;rc"»a\·c Santpfo 
Preparation S}'stem and may need to be modified or <J.ang-ed !o Qt:-t.ain tfle. reqt1 Ired res<rlts lJP ycur sample. 
Hold(min) 
15:00 
NOTE B: f\1a:m.i:ei: -..-enring ofCEM dosed veSiels shoal.a only 1::-e perfimned ""'hen \~'earing h2n<l. eye and bt:>dy prntectfo:t 
and fl'r.~Y \\•hen !he vessel cor.tcots are at or Dclow room temperature to .a\·ot.d the pote11tial for chemical bums. Al:w:1ys p-.)int 
the \·ent fl.;)k awa.y from t:te operator and tov.:-ard the bacli: of a fume h">o.;l 
i\"Ol'f. C: P-0we.--:sh;flufd be adjusted up.or dot'rin wi~h respect to Lhe- t1 t.::ntf.e.r of ,,.-.;ssds_ Ge.,.e"ral guideHn.::s are as f{)JlfllJ. s: 
g..12 vt"SSe!s (50% pov.1:·rJ 13-20- -..-essds {7:5~-t. f'O-'t\."CT), >2-0 ve.s...---els (ioef.:1t. p(rr,;,.-cr}. 
SO'ff: n: "'OrgJ:ni:c Method Sample Type·· should 00 used fo-r mosl $ample types. Choose "lnnrg.inic" fer sa.mpJes ,-i,.ith 
more than I gram of SQlid materiit[ rernalning at the bouom of the \'es5'!l at the. enCI Qfth.;; digc!>t (<::x l-eai.h methodsj. Cf,L,lHt; 
"V.'ater·· i(.r sarnp[es that ar-e targcty aq>renus p;iu-r ta digesl Lon. 
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